JP2020079239A - Antifungal agent - Google Patents
Antifungal agent Download PDFInfo
- Publication number
- JP2020079239A JP2020079239A JP2019204773A JP2019204773A JP2020079239A JP 2020079239 A JP2020079239 A JP 2020079239A JP 2019204773 A JP2019204773 A JP 2019204773A JP 2019204773 A JP2019204773 A JP 2019204773A JP 2020079239 A JP2020079239 A JP 2020079239A
- Authority
- JP
- Japan
- Prior art keywords
- group
- monomer
- mass
- meth
- antifungal agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940121375 antifungal agent Drugs 0.000 title claims abstract description 84
- 239000003429 antifungal agent Substances 0.000 title claims abstract description 52
- 239000000178 monomer Substances 0.000 claims abstract description 161
- 229920001577 copolymer Polymers 0.000 claims abstract description 104
- 125000002091 cationic group Chemical group 0.000 claims abstract description 81
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 26
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 18
- 125000001033 ether group Chemical group 0.000 claims abstract description 15
- 125000000524 functional group Chemical group 0.000 claims abstract description 12
- 229920001519 homopolymer Polymers 0.000 claims abstract description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 36
- 239000007864 aqueous solution Substances 0.000 claims description 34
- 238000003756 stirring Methods 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 33
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- 125000001302 tertiary amino group Chemical group 0.000 claims description 20
- 239000002537 cosmetic Substances 0.000 claims description 16
- 239000001965 potato dextrose agar Substances 0.000 claims description 16
- 210000004027 cell Anatomy 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 14
- 150000007513 acids Chemical class 0.000 claims description 13
- 239000000725 suspension Substances 0.000 claims description 10
- 238000005259 measurement Methods 0.000 claims description 6
- 241001149955 Cladosporium cladosporioides Species 0.000 claims description 3
- 210000000601 blood cell Anatomy 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 229920000642 polymer Polymers 0.000 abstract description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 105
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 74
- 238000006116 polymerization reaction Methods 0.000 description 51
- -1 acrylate ester Chemical class 0.000 description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 239000000047 product Substances 0.000 description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 30
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 24
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 20
- 150000002430 hydrocarbons Chemical group 0.000 description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- 238000003786 synthesis reaction Methods 0.000 description 17
- 239000007787 solid Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 239000002904 solvent Substances 0.000 description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- LBSPZZSGTIBOFG-UHFFFAOYSA-N bis[2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene;dihydrochloride Chemical compound Cl.Cl.N=1CCNC=1C(C)(C)N=NC(C)(C)C1=NCCN1 LBSPZZSGTIBOFG-UHFFFAOYSA-N 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 13
- 210000003608 fece Anatomy 0.000 description 13
- 230000002431 foraging effect Effects 0.000 description 13
- 239000011521 glass Substances 0.000 description 13
- 239000003505 polymerization initiator Substances 0.000 description 13
- 238000010992 reflux Methods 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 10
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000007334 copolymerization reaction Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 239000003599 detergent Substances 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 6
- 210000002421 cell wall Anatomy 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 150000005846 sugar alcohols Polymers 0.000 description 6
- SJIXRGNQPBQWMK-UHFFFAOYSA-N DEAEMA Natural products CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 5
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 150000007522 mineralic acids Chemical class 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 230000000379 polymerizing effect Effects 0.000 description 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 150000003926 acrylamides Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 239000004568 cement Substances 0.000 description 3
- 150000004292 cyclic ethers Chemical class 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 230000009036 growth inhibition Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 239000008235 industrial water Substances 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920001131 Pulp (paper) Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 239000012911 assay medium Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910000000 metal hydroxide Inorganic materials 0.000 description 2
- 150000004692 metal hydroxides Chemical class 0.000 description 2
- 150000002763 monocarboxylic acids Chemical class 0.000 description 2
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- OTJFQRMIRKXXRS-UHFFFAOYSA-N (hydroxymethylamino)methanol Chemical compound OCNCO OTJFQRMIRKXXRS-UHFFFAOYSA-N 0.000 description 1
- MJYFYGVCLHNRKB-UHFFFAOYSA-N 1,1,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(F)(F)CF MJYFYGVCLHNRKB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 1
- KQIXMZWXFFHRAQ-UHFFFAOYSA-N 1-(2-hydroxybutylamino)butan-2-ol Chemical compound CCC(O)CNCC(O)CC KQIXMZWXFFHRAQ-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- TZJQCUDHKUWEFU-UHFFFAOYSA-N 2,2-dimethylpentanenitrile Chemical compound CCCC(C)(C)C#N TZJQCUDHKUWEFU-UHFFFAOYSA-N 0.000 description 1
- BJELTSYBAHKXRW-UHFFFAOYSA-N 2,4,6-triallyloxy-1,3,5-triazine Chemical compound C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1 BJELTSYBAHKXRW-UHFFFAOYSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- LSWYGACWGAICNM-UHFFFAOYSA-N 2-(prop-2-enoxymethyl)oxirane Chemical compound C=CCOCC1CO1 LSWYGACWGAICNM-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- LYPGJGCIPQYQBW-UHFFFAOYSA-N 2-methyl-2-[[2-methyl-1-oxo-1-(prop-2-enylamino)propan-2-yl]diazenyl]-n-prop-2-enylpropanamide Chemical compound C=CCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCC=C LYPGJGCIPQYQBW-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- NMZSJIQGMAGSSO-UHFFFAOYSA-N 3-[[1-amino-2-[[1-amino-1-(2-carboxyethylimino)-2-methylpropan-2-yl]diazenyl]-2-methylpropylidene]amino]propanoic acid Chemical compound OC(=O)CCNC(=N)C(C)(C)N=NC(C)(C)C(=N)NCCC(O)=O NMZSJIQGMAGSSO-UHFFFAOYSA-N 0.000 description 1
- HNVRRHSXBLFLIG-UHFFFAOYSA-N 3-hydroxy-3-methylbut-1-ene Chemical compound CC(C)(O)C=C HNVRRHSXBLFLIG-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- CYUZOYPRAQASLN-UHFFFAOYSA-N 3-prop-2-enoyloxypropanoic acid Chemical compound OC(=O)CCOC(=O)C=C CYUZOYPRAQASLN-UHFFFAOYSA-N 0.000 description 1
- VFXXTYGQYWRHJP-UHFFFAOYSA-N 4,4'-azobis(4-cyanopentanoic acid) Chemical compound OC(=O)CCC(C)(C#N)N=NC(C)(CCC(O)=O)C#N VFXXTYGQYWRHJP-UHFFFAOYSA-N 0.000 description 1
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical compound NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- WIYVVIUBKNTNKG-UHFFFAOYSA-N 6,7-dimethoxy-3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C1CC(C(O)=O)=CC2=C1C=C(OC)C(OC)=C2 WIYVVIUBKNTNKG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000223600 Alternaria Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241001331781 Aspergillus brasiliensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 229920000028 Gradient copolymer Polymers 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- IAXXETNIOYFMLW-COPLHBTASA-N [(1s,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C(=C)C)C[C@H]1C2(C)C IAXXETNIOYFMLW-COPLHBTASA-N 0.000 description 1
- KYIKRXIYLAGAKQ-UHFFFAOYSA-N abcn Chemical compound C1CCCCC1(C#N)N=NC1(C#N)CCCCC1 KYIKRXIYLAGAKQ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- JZQAAQZDDMEFGZ-UHFFFAOYSA-N bis(ethenyl) hexanedioate Chemical compound C=COC(=O)CCCCC(=O)OC=C JZQAAQZDDMEFGZ-UHFFFAOYSA-N 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- LWMFAFLIWMPZSX-UHFFFAOYSA-N bis[2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene Chemical compound N=1CCNC=1C(C)(C)N=NC(C)(C)C1=NCCN1 LWMFAFLIWMPZSX-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000012986 chain transfer agent Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005070 decynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- LAWOZCWGWDVVSG-UHFFFAOYSA-N dioctylamine Chemical compound CCCCCCCCNCCCCCCCC LAWOZCWGWDVVSG-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- IYNRVIKPUTZSOR-HWKANZROSA-N ethenyl (e)-but-2-enoate Chemical compound C\C=C\C(=O)OC=C IYNRVIKPUTZSOR-HWKANZROSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 238000010559 graft polymerization reaction Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229940119545 isobornyl methacrylate Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000010550 living polymerization reaction Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical class 0.000 description 1
- XMYQHJDBLRZMLW-UHFFFAOYSA-N methanolamine Chemical compound NCO XMYQHJDBLRZMLW-UHFFFAOYSA-N 0.000 description 1
- 229940087646 methanolamine Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- ZQMHJBXHRFJKOT-UHFFFAOYSA-N methyl 2-[(1-methoxy-2-methyl-1-oxopropan-2-yl)diazenyl]-2-methylpropanoate Chemical compound COC(=O)C(C)(C)N=NC(C)(C)C(=O)OC ZQMHJBXHRFJKOT-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- MJCJUDJQDGGKOX-UHFFFAOYSA-N n-dodecyldodecan-1-amine Chemical compound CCCCCCCCCCCCNCCCCCCCCCCCC MJCJUDJQDGGKOX-UHFFFAOYSA-N 0.000 description 1
- NJWMENBYMFZACG-UHFFFAOYSA-N n-heptylheptan-1-amine Chemical compound CCCCCCCNCCCCCCC NJWMENBYMFZACG-UHFFFAOYSA-N 0.000 description 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 description 1
- JACMPVXHEARCBO-UHFFFAOYSA-N n-pentylpentan-1-amine Chemical compound CCCCCNCCCCC JACMPVXHEARCBO-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005071 nonynyl group Chemical group C(#CCCCCCCC)* 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 125000005064 octadecenyl group Chemical group C(=CCCCCCCCCCCCCCCCC)* 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940100684 pentylamine Drugs 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XHGIFBQQEGRTPB-UHFFFAOYSA-N tris(prop-2-enyl) phosphate Chemical compound C=CCOP(=O)(OCC=C)OCC=C XHGIFBQQEGRTPB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003171 wood protecting agent Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Description
本発明は、抗カビ剤に関する。より詳しくは、洗浄剤、化粧料、塗料、樹脂、木材防腐剤、セメント混和剤、水処理剤、工業用水、紙パルプ、プラスチック、繊維、食品添加物、医療機器、光学機器、モジュール、電子製品等に有用な抗カビ剤に関する。 The present invention relates to antifungal agents. More specifically, detergents, cosmetics, paints, resins, wood preservatives, cement admixtures, water treatment agents, industrial water, paper pulp, plastics, fibers, food additives, medical equipment, optical equipment, modules, electronic products. The present invention relates to a useful antifungal agent.
近年、消費者の清潔志向及び衛生上の観点から、種々の日用品、工業製品に抗菌処理を施すことが求められている。このような抗菌処理に用いられる抗菌剤として、例えば特許文献1には、カチオン性基含有共重合体を含む抗菌剤であって、該共重合体は、カチオン性基含有単量体由来の構造単位と疎水性単量体由来の構造単位とを有し、該カチオン性基含有単量体由来の構造単位の割合が、全構造単位100質量%に対して36〜99.9質量%であり、重量平均分子量が4000〜100万であり、該疎水性単量体は、単独重合体の溶解性パラメータが15以下であることを特徴とするカチオン性基含有共重合体を含む抗菌剤が開示されている。
高温多湿な日本では、細菌の増殖を抑制することのみならず、カビの繁殖を抑制することも重要視されている。抗カビの技術に関して、例えば特許文献2には、寒天培地に対象となる組成物及びカビの胞子懸濁液を塗抹し、静置培養した後にカビのコロニー数を計数し、当該コロニー数を対照と比較すること、を特徴とする組成物の防カビ効果確認方法が開示されている。
特許文献3には、単量体水溶液の重合工程、乾燥工程、及び表面架橋工程を含む、ポリアクリル酸(塩)系吸水剤の製造方法であって、単量体又はその重合体に含まれる酢酸及びプロピオン酸の合計量を200〜2500ppmとし、表面架橋された吸水性樹脂粒子に対して、殺菌成分を含む水性液を添加する工程を更に含む、ポリアクリル酸(塩)系吸水剤の製造方法が開示されている。
In recent years, from the viewpoint of consumer's cleanliness and hygiene, various daily products and industrial products are required to be subjected to antibacterial treatment. As an antibacterial agent used for such an antibacterial treatment, for example, Patent Document 1 discloses an antibacterial agent containing a cationic group-containing copolymer, wherein the copolymer has a structure derived from a cationic group-containing monomer. Unit and a structural unit derived from a hydrophobic monomer, and the ratio of the structural unit derived from the cationic group-containing monomer is 36 to 99.9 mass% with respect to 100 mass% of all structural units. Disclosed is an antibacterial agent containing a cationic group-containing copolymer, wherein the hydrophobic monomer has a weight average molecular weight of 4000 to 1,000,000 and a homopolymer has a solubility parameter of 15 or less. Has been done.
In hot and humid Japan, it is important not only to suppress the growth of bacteria but also to suppress the growth of mold. Regarding the antifungal technique, for example, in Patent Document 2, agar medium is smeared with a composition of interest and a mold spore suspension, and after static culture, the number of mold colonies is counted, and the number of colonies is used as a control. The method for confirming the antifungal effect of the composition is disclosed, which is characterized in that
Patent Document 3 is a method for producing a polyacrylic acid (salt)-based water-absorbing agent, which comprises a step of polymerizing an aqueous solution of a monomer, a drying step, and a surface-crosslinking step, and is included in a monomer or a polymer thereof. Production of a polyacrylic acid (salt)-based water-absorbing agent, wherein the total amount of acetic acid and propionic acid is 200 to 2500 ppm, and further including a step of adding an aqueous liquid containing a bactericidal component to the surface-crosslinked water-absorbing resin particles. A method is disclosed.
上述のとおり、従来抗菌剤等が種々開発されているが、真核生物であるカビに対して特に有効な抗カビ剤を開発する余地があった。 As described above, although various antibacterial agents and the like have been conventionally developed, there is room for developing an antifungal agent that is particularly effective against fungi that are eukaryotes.
本発明は、上記現状に鑑みてなされたものであり、抗カビ性能に優れる重合体を含む抗カビ剤を提供することを目的とする。 The present invention has been made in view of the above circumstances, and an object thereof is to provide an antifungal agent containing a polymer having excellent antifungal performance.
本発明者らは、重合体について種々検討したところ、カチオン性基含有単量体由来の構造単位と特定の単量体由来の構造単位とを有し、カチオン性基含有単量体由来の構造単位の割合及び重量平均分子量が特定の範囲である共重合体が、抗カビ性能に優れることを見いだし、上記課題をみごとに解決することができることに想到し、本発明に到達したものである。 The present inventors have conducted various studies on polymers, and have a structural unit derived from a cationic group-containing monomer and a structural unit derived from a specific monomer, and a structure derived from a cationic group-containing monomer. The inventors have found that a copolymer having a unit ratio and a weight average molecular weight within a specific range has excellent antifungal performance, and thought that the above-mentioned problems could be solved satisfactorily, and thus arrived at the present invention.
すなわち本発明は、カチオン性基含有共重合体を含む抗カビ剤であって、該抗カビ剤は、下記の方法により測定される抗カビ能が2.0以上であり、該カチオン性基含有共重合体は、カチオン性基含有単量体(A)由来の構造単位(a)と単量体(B)由来の構造単位(b)とを有し、該カチオン性基含有単量体(A)由来の構造単位(a)の割合が、全構造単位100質量%に対して36〜99.9質量%であり、該単量体(B)は、単独重合体の溶解性パラメータが10以下である単量体(B1)、並びに、カルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有する単量体(B2)、から選択される1種以上の単量体であり、該カチオン性基含有共重合体の重量平均分子量が4000〜100万であり、抗カビ剤に含まれる該カチオン性基含有共重合体の割合が抗カビ剤100質量%に対して10〜100質量%である抗カビ剤である。
<抗カビ能の測定>
1)ポテトデキストロース寒天(PDA)斜面培地にクロカビ(Cladosporium cladosporioides)を植菌し、30℃で1週間前培養する。
2)生育したクロカビから胞子懸濁液を調製し、血球盤で胞子数をカウントして適宜希釈することにより約5.0×104 spores/mlの濃度に調整する。この時、調整後の胞子懸濁液を適宜希釈してPDA培地に100μL塗布し、30℃で3日間培養することにより、実際の生菌数を求め、これを初期の生菌数αとする。
3)1.5mlチューブに当該カチオン性基含有共重合体の20%水溶液500μLと調整後の胞子懸濁液500μLを入れ、ツインミキサーで撹拌する。攪拌180分後の試料をPDA培地に100μl塗抹し、30℃で3日間培養することにより、生菌数を求め、これを撹拌180分後の試料中の生菌数βとする。
4)下記式(1)により抗カビ能を算出する。
抗カビ能=2−log[(β/α)×100](1)
That is, the present invention is an antifungal agent containing a cationic group-containing copolymer, wherein the antifungal agent has an antifungal ability of 2.0 or more as measured by the following method, The copolymer has a structural unit (a) derived from the cationic group-containing monomer (A) and a structural unit (b) derived from the monomer (B), and the cationic group-containing monomer ( The proportion of the structural unit (a) derived from A) is 36 to 99.9 mass% with respect to 100 mass% of all structural units, and the monomer (B) has a solubility parameter of a homopolymer of 10%. One or more monomers selected from the following monomers (B1) and monomers (B2) having at least one functional group selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group. The cationic group-containing copolymer has a weight average molecular weight of 4000 to 1,000,000 and the ratio of the cationic group-containing copolymer contained in the antifungal agent is 100% by mass of the antifungal agent. The antifungal agent is 10 to 100% by mass.
<Measurement of antifungal ability>
1) Potato dextrose agar (PDA) slope medium is inoculated with black mold (Cladosporium cladosporioides), and precultured at 30° C. for 1 week.
2) A spore suspension is prepared from the grown black mold, and the number of spores is counted in a blood cell disc and appropriately diluted to adjust the concentration to about 5.0×10 4 pores/ml. At this time, the adjusted spore suspension is appropriately diluted, applied to a PDA medium in an amount of 100 μL, and cultured at 30° C. for 3 days to obtain the actual viable cell count, which is used as the initial viable cell count α. ..
3) Into a 1.5 ml tube, 500 μL of a 20% aqueous solution of the cationic group-containing copolymer and 500 μL of the adjusted spore suspension are put and stirred with a twin mixer. 100 μl of the sample after 180 minutes of stirring is smeared on a PDA medium and cultured at 30° C. for 3 days to obtain the viable cell count, which is defined as the viable cell number β in the sample after 180 minutes of stirring.
4) The antifungal ability is calculated by the following formula (1).
Antifungal ability=2-log [(β/α)×100] (1)
本発明の抗カビ剤は、上述の構成よりなり、抗カビ能に優れるため、洗浄剤、化粧料、塗料、樹脂、木材防腐剤、セメント混和剤、水処理剤、工業用水、紙パルプ、プラスチック、繊維、食品添加物、医療機器、光学機器、モジュール、電子製品等に好適に用いることができる。 The antifungal agent of the present invention has the above-mentioned constitution and is excellent in antifungal ability, so that it is a detergent, cosmetic, paint, resin, wood preservative, cement admixture, water treatment agent, industrial water, paper pulp, plastic. , Fibers, food additives, medical devices, optical devices, modules, electronic products and the like.
以下に本発明の好ましい形態について具体的に説明するが、本発明は以下の記載のみに限定されるものではなく、本発明の要旨を変更しない範囲において適宜変更して適用することができる。なお、以下に記載される本発明の個々の好ましい形態を2又は3以上組み合わせた形態も、本発明の好ましい形態に該当する。 The preferred embodiments of the present invention will be specifically described below, but the present invention is not limited to the following description and can be appropriately modified and applied without changing the gist of the present invention. It should be noted that a combination of two or more individual preferred embodiments of the present invention described below also corresponds to the preferred embodiment of the present invention.
≪抗カビ剤≫
本発明における抗カビ剤とは抗カビ性能を有する剤のことをいう。抗カビ性能とは、カビの増殖を抑える、カビを殺す、防カビ等の性能を有することをいう。対象となるカビとしては、特に制限されないが、例えば、ペニシリウム(Penicillium)属に属する微生物、アスペルギルス(Aspergillus)属に属する微生物、クラドスポリウム(Cladosporium)属に属する微生物、フザリウム(Fusarium)属に属する微生物、アルテルナリア(Alternaria)属に属する微生物、リゾプス(Rhizopus)属に属する微生物等が挙げられる。
<<Antifungal agent>>
The antifungal agent in the present invention refers to an agent having antifungal properties. The antifungal performance means having properties such as suppressing the growth of mold, killing mold, and preventing mold. The target mold is not particularly limited, but includes, for example, microorganisms belonging to the genus Penicillium, microorganisms belonging to the genus Aspergillus, microorganisms belonging to the genus Cladosporium, and belonging to the genus Fusarium. Examples thereof include microorganisms, microorganisms belonging to the genus Alternaria, microorganisms belonging to the genus Rhizopus, and the like.
本発明の抗カビ剤に含まれるカチオン性基含有共重合体(以下、本発明の共重合体ともいう)は、上記の方法により測定される抗カビ能が2.0以上である。
上記抗カビ能として好ましくは2.5以上であり、更に好ましくは3.0以上であり、特に好ましくは3.5以上である。
抗カビ能の測定方法の詳細は実施例のとおりである。
The cationic group-containing copolymer contained in the antifungal agent of the present invention (hereinafter also referred to as the copolymer of the present invention) has an antifungal ability of 2.0 or more as measured by the above method.
The antifungal activity is preferably 2.5 or more, more preferably 3.0 or more, and particularly preferably 3.5 or more.
The details of the method for measuring the antifungal ability are as described in the examples.
上記カチオン性基含有共重合体は、全構造単位100質量%に対して、カチオン性基含有単量体(A)由来の構造単位(a)を36〜99.9質量%の割合で有する。好ましくは40〜99質量%、より好ましくは45〜99質量%であり、更に好ましくは50〜95質量%であり、一層好ましくは60〜90質量%である。 The cationic group-containing copolymer has the structural unit (a) derived from the cationic group-containing monomer (A) in a proportion of 36 to 99.9% by mass based on 100% by mass of all structural units. It is preferably 40 to 99% by mass, more preferably 45 to 99% by mass, further preferably 50 to 95% by mass, and further preferably 60 to 90% by mass.
上記カチオン性基含有共重合体は、カチオン性基含有単量体(A)が第1〜3級アミノ基含有単量体(A1)及び/又はこれらの酸による中和物の場合、カチオン性基含有単量体(A1)由来の構造単位(a1)の割合は、全構造単位100質量%に対して36〜99.9質量%であることが好ましい。すなわち、上記カチオン性基含有単量体(A)が、第1〜3級アミノ基含有単量体(A1)及び/又はこれらの酸による中和物であり、第1〜3級アミノ基含有単量体(A1)及び/又はこれらの酸による中和物由来の構造単位(a1)の割合が、全構造単位100質量%に対して36〜99.9質量%であるカチオン性基含有共重合体も本発明の1つである。
上記割合として好ましくは40〜99質量%、より好ましくは45〜99質量%であり、更に好ましくは50〜95質量%であり、一層好ましくは60〜90質量%である。
なお、構造単位(a)及び(a1)におけるアミノ基が、アミン塩基の酸による中和物である場合、構造単位(a)及び(a1)の質量は、中和前の構造単位に換算して質量を計算するものとする。
When the cationic group-containing monomer (A) is a neutralized product of the primary to tertiary amino group-containing monomer (A1) and/or an acid thereof, the cationic group-containing copolymer is cationic. The proportion of the structural unit (a1) derived from the group-containing monomer (A1) is preferably 36 to 99.9 mass% with respect to 100 mass% of all structural units. That is, the cationic group-containing monomer (A) is a neutralized product of the primary to tertiary amino group-containing monomer (A1) and/or an acid thereof, and contains a primary to tertiary amino group. A cationic group-containing copolymer in which the proportion of the structural unit (a1) derived from the monomer (A1) and/or a neutralized product of these acids is 36 to 99.9% by mass based on 100% by mass of all structural units. A polymer is also one of the present inventions.
The above ratio is preferably 40 to 99% by mass, more preferably 45 to 99% by mass, further preferably 50 to 95% by mass, and further preferably 60 to 90% by mass.
When the amino groups in the structural units (a) and (a1) are neutralized products of an amine base with an acid, the masses of the structural units (a) and (a1) are converted into the structural units before neutralization. And calculate the mass.
上記カチオン性基含有単量体(A)が、後述する式(4−1)又は(4−2)で表される構造であって、R3、R4がメチル基である場合、構造単位(a)の含有割合は、40〜95質量%であることが好ましい。より好ましくは50〜90質量%であり、更に好ましくは60〜90質量%であり、特に好ましくは70〜90質量%である。
上記カチオン性基含有単量体(A)が、後述する式(4−1)又は(4−2)で表される構造であって、R3、R4が炭素数2以上の炭化水素基である場合、構造単位(a)の含有割合は、40〜90質量%であることが好ましい。より好ましくは45〜85質量%であり、更に好ましくは50〜80質量%であり、一層好ましくは55〜80質量%であり、特に好ましくは60〜80質量%であり、最も好ましくは65〜80質量%である。
When the cationic group-containing monomer (A) has a structure represented by the formula (4-1) or (4-2) described below and R 3 and R 4 are methyl groups, a structural unit The content ratio of (a) is preferably 40 to 95% by mass. It is more preferably 50 to 90% by mass, further preferably 60 to 90% by mass, and particularly preferably 70 to 90% by mass.
The above-mentioned cationic group-containing monomer (A) has a structure represented by the formula (4-1) or (4-2) described below, and R 3 and R 4 are hydrocarbon groups having 2 or more carbon atoms. When it is, the content ratio of the structural unit (a) is preferably 40 to 90 mass %. It is more preferably 45 to 85% by mass, further preferably 50 to 80% by mass, further preferably 55 to 80% by mass, particularly preferably 60 to 80% by mass, and most preferably 65 to 80% by mass. It is% by mass.
本発明のカチオン性基含有共重合体は、全構造単位100質量%に対して、単量体(B)由来の構造単位(b)を0.1〜64質量%の割合で有することが好ましい。より好ましくは1〜60質量%、更に好ましくは1〜55質量%であり、一層好ましくは5〜50質量%であり、更に一層好ましくは10〜40質量%である。 The cationic group-containing copolymer of the present invention preferably has the structural unit (b) derived from the monomer (B) in a proportion of 0.1 to 64 mass% with respect to 100 mass% of all the structural units. .. It is more preferably 1 to 60% by mass, still more preferably 1 to 55% by mass, still more preferably 5 to 50% by mass, and still more preferably 10 to 40% by mass.
本発明の共重合体は、共重合体における単量体(B)由来の構造単位(b)の含有割合が、カチオン性基含有単量体(A)由来の構造単位(a)100質量%に対して、1〜150質量%であることが好ましい。より好ましくは1〜120質量%、更に好ましくは5〜100質量%であり、一層好ましくは10〜60質量%である。本発明の共重合体における構造単位(b)の含有割合がこのような範囲であれば、上記共重合体の抗カビ性能が向上する傾向にある。 In the copolymer of the present invention, the content ratio of the structural unit (b) derived from the monomer (B) in the copolymer is 100% by mass of the structural unit (a) derived from the cationic group-containing monomer (A). On the other hand, it is preferably 1 to 150% by mass. The amount is more preferably 1 to 120% by mass, further preferably 5 to 100% by mass, and further preferably 10 to 60% by mass. When the content ratio of the structural unit (b) in the copolymer of the present invention is within such a range, the antifungal performance of the above copolymer tends to be improved.
上記共重合体は、単量体(B1)由来の構造単位(b1)の含有割合が、全構造単位100質量%に対して、0.1〜64質量%であることが好ましい。より好ましくは1〜60質量%、更に好ましくは1〜55質量%、一層好ましくは5〜50質量%、更に一層好ましくは10〜40質量%である。
上記共重合体は、単量体(B2)由来の構造単位(b2)の含有割合が、全構造単位100質量%に対して、0〜30質量%であることが好ましい。より好ましくは0〜20質量%、更に好ましくは0〜10質量%である。
In the copolymer, the content ratio of the structural unit (b1) derived from the monomer (B1) is preferably 0.1 to 64 mass% with respect to 100 mass% of all structural units. It is more preferably 1 to 60% by mass, still more preferably 1 to 55% by mass, still more preferably 5 to 50% by mass, and still more preferably 10 to 40% by mass.
In the above copolymer, the content ratio of the structural unit (b2) derived from the monomer (B2) is preferably 0 to 30 mass% with respect to 100 mass% of all structural units. It is more preferably 0 to 20% by mass, and further preferably 0 to 10% by mass.
本発明の共重合体は後述するとおり、単量体(B1)として、(メタ)アクリル酸アルキルエステル由来の構造単位と、更にカルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有する単量体(B2)由来の構造単位(b2)とを有していてもよく、上記共重合体におけるカルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有する単量体(B2)由来の構造単位(b2)の割合は、(メタ)アクリル酸アルキルエステル由来の構造単位100質量%に対して、0〜100質量%であることが好ましい。より好ましくは0〜50質量%であり、更に好ましくは0〜40質量%であり、特に好ましくは0.1〜30質量%である。 As will be described later, the copolymer of the present invention has, as the monomer (B1), at least one structural unit derived from an alkyl (meth)acrylate ester, and at least one selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group. And a structural unit (b2) derived from the monomer (B2) having a functional group of at least one kind selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group in the above copolymer. The proportion of the structural unit (b2) derived from the monomer (B2) having a functional group is preferably 0 to 100% by mass based on 100% by mass of the structural unit derived from the (meth)acrylic acid alkyl ester. It is more preferably 0 to 50% by mass, further preferably 0 to 40% by mass, and particularly preferably 0.1 to 30% by mass.
本発明の共重合体が単量体(B1)として(メタ)アクリル酸アルキルエステル由来の構造単位を有する場合、(メタ)アクリル酸アルキルエステル由来の構造単位の割合は、全構造単位100質量%に対して、0.1〜64質量%であることが好ましい。より好ましくは1〜60質量%、更に好ましくは1〜55質量%、一層好ましくは、5〜50質量%、更に一層好ましくは10〜40質量%である。 When the copolymer of the present invention has a structural unit derived from (meth)acrylic acid alkyl ester as the monomer (B1), the proportion of structural units derived from (meth)acrylic acid alkyl ester is 100% by mass of all structural units. On the other hand, it is preferably 0.1 to 64% by mass. The amount is more preferably 1 to 60% by mass, still more preferably 1 to 55% by mass, still more preferably 5 to 50% by mass, and still more preferably 10 to 40% by mass.
本発明の共重合体は、後述するとおり、上記カチオン性基含有単量体(A)及び単量体(B)以外のその他の単量体(E)由来の構造単位(e)を有していてもよく、その他の単量体(E)由来の構造単位(e)の含有割合は、全構造単位100質量%に対して、0〜10質量%であることが好ましい。より好ましくは、0〜8質量%、更に好ましくは0〜5質量%である。 As will be described later, the copolymer of the present invention has a structural unit (e) derived from another monomer (E) other than the above-mentioned cationic group-containing monomer (A) and monomer (B). The content ratio of the structural unit (e) derived from the other monomer (E) is preferably 0 to 10 mass% with respect to 100 mass% of all the structural units. It is more preferably 0 to 8% by mass, and further preferably 0 to 5% by mass.
本発明の共重合体としては、カチオン性基含有単量体(A)由来の構造単位(a)と単量体(B)由来の構造単位(b)のみからなる共重合体もまた、好ましい形態の1つである。この場合、カチオン性基含有単量体(A)由来の構造単位(a)と単量体由来の構造単位の割合の合計は100質量%であり、これらの構造単位のそれぞれの割合は、100質量%から上述のカチオン性基含有単量体(A)由来の構造単位(a)の割合又は単量体(B)由来の構造単位(b)の割合を差し引いた値となる。 As the copolymer of the present invention, a copolymer comprising only the structural unit (a) derived from the cationic group-containing monomer (A) and the structural unit (b) derived from the monomer (B) is also preferable. It is one of the forms. In this case, the total of the ratio of the structural unit (a) derived from the cationic group-containing monomer (A) and the structural unit derived from the monomer was 100% by mass, and the ratio of each of these structural units was 100. It is a value obtained by subtracting the ratio of the structural unit (a) derived from the cationic group-containing monomer (A) or the ratio of the structural unit (b) derived from the monomer (B) from mass %.
本発明のカチオン性基含有共重合体の重量平均分子量は、4000〜100万である。カチオン性基含有共重合体の重量平均分子量がこのような範囲であれば、抗カビ剤を使用する素材に対する抗カビ剤の吸着性が向上するため、洗浄した際に洗い流されることを充分に抑制し、上記素材に対する抗カビ作用が向上する。
上記重量平均分子量として好ましくは4000〜80万であり、より好ましくは5000〜60万であり、更に好ましくは6000〜40万であり、一層好ましくは7000〜20万であり、更に一層好ましくは7000〜10万であり、特に好ましくは7000〜8万である。カチオン性基含有共重合体の重量平均分子量は、実施例に記載の方法により測定することができる。
The cationic group-containing copolymer of the present invention has a weight average molecular weight of 4000 to 1,000,000. When the weight average molecular weight of the cationic group-containing copolymer is in such a range, the adsorption of the antifungal agent to the material using the antifungal agent is improved, so that it is sufficiently prevented from being washed off when washed. However, the antifungal effect on the above materials is improved.
The weight average molecular weight is preferably 4,000 to 800,000, more preferably 5,000 to 600,000, still more preferably 6,000 to 400,000, further preferably 7,000 to 200,000, and still more preferably 7,000 to 7,000. It is 100,000, and particularly preferably 7,000 to 80,000. The weight average molecular weight of the cationic group-containing copolymer can be measured by the method described in Examples.
本発明のカチオン性基含有共重合体の構造はランダム共重合体構造、グラフト構造、ブロック共重合体構造、グラジエント共重合体構造、星形構造、デンドリマー構造などが挙げられるが、いずれの構造であってもよい。 The structure of the cationic group-containing copolymer of the present invention includes random copolymer structure, graft structure, block copolymer structure, gradient copolymer structure, star structure, dendrimer structure, etc. It may be.
本発明の抗カビ剤は、カチオン性基含有共重合体と有機酸及び/又は無機酸とを含むことが好ましい。これにより、本発明の抗カビ剤の抗カビ性能がより向上する。
上記有機酸としては、酢酸、クエン酸、酒石酸、トルエンスルホン酸、乳酸、コハク酸、グリコール酸等が挙げられる。上記無機酸としては、塩酸、硫酸、硝酸、リン酸等が挙げられる。好ましくは有機酸であり、より好ましくは酢酸、クエン酸、塩酸であり、特に好ましくは酢酸である。
上記抗カビ剤における有機酸及び/又は無機酸の含有割合は特に制限されないが、カチオン性基含有共重合体の構造単位(a)1規定に対して有機酸及び/又は無機酸の含有割合が0.5〜2規定であることが好ましい。より好ましくは0.8〜1.5規定であり、更に好ましくは1.0〜1.2規定である。
The antifungal agent of the present invention preferably contains a cationic group-containing copolymer and an organic acid and/or an inorganic acid. This further improves the antifungal performance of the antifungal agent of the present invention.
Examples of the organic acid include acetic acid, citric acid, tartaric acid, toluenesulfonic acid, lactic acid, succinic acid, glycolic acid and the like. Examples of the inorganic acid include hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid and the like. Organic acids are preferable, acetic acid, citric acid and hydrochloric acid are more preferable, and acetic acid is particularly preferable.
The content ratio of the organic acid and/or the inorganic acid in the above antifungal agent is not particularly limited, but the content ratio of the organic acid and/or the inorganic acid is 1 relative to 1 unit of the structural unit (a) of the cationic group-containing copolymer. It is preferably 0.5 to 2 normal. It is more preferably 0.8 to 1.5, and even more preferably 1.0 to 1.2.
<カチオン性基含有単量体(A)>
本発明の抗カビ剤に含まれるカチオン性基含有共重合体は、カチオン性基含有単量体(A)由来の構造単位(a)を有している。上記カチオン性基含有単量体は、エチレン性不飽和基とカチオン性基とを少なくとも1つずつ有していれば、特に制限されない。また、「カチオン性基含有単量体(A)由来の構造単位(a)」とは、単量体(A)が重合して形成される構造単位と同じ構造であれば、別の製法により形成されたものであってもよい。後述する単量体(B)及び単量体(E)についても同様である。例えば、単量体(A)がN,N−ジメチルアミノエチルメタクリレートである場合、構造単位(a)は、−CH2−C(CH3)(COCH2CH2−N(CH3)2)−で表される構造単位である。ここでカチオン性基とは、カチオンを有する基又はカチオンを発生させる基であり、例えば、第1〜3級アミノ基、第1〜3級アミノ基の酸による中和物等が挙げられる。第1〜3級アミノ基としては、下記式(2);
<Cationic group-containing monomer (A)>
The cationic group-containing copolymer contained in the antifungal agent of the present invention has the structural unit (a) derived from the cationic group-containing monomer (A). The cationic group-containing monomer is not particularly limited as long as it has at least one ethylenically unsaturated group and at least one cationic group. In addition, the “structural unit (a) derived from the cationic group-containing monomer (A)” is the same as the structural unit formed by the polymerization of the monomer (A), and it may be produced by another production method. It may be formed. The same applies to the monomer (B) and the monomer (E) described later. For example, when the monomer (A) is N,N-dimethylaminoethyl methacrylate, the structural unit (a) has —CH 2 —C(CH 3 )(COCH 2 CH 2 —N(CH 3 ) 2 ). It is a structural unit represented by-. Here, the cationic group is a group having a cation or a group generating a cation, and examples thereof include a primary to tertiary amino group and a neutralized product of the primary to tertiary amino group with an acid. As the primary to tertiary amino groups, the following formula (2);
(式中、R1及びR2は、同一又は異なって、水素原子、炭素数1〜12の炭化水素基を表す。)で表される構造であることが好ましい。
上記炭化水素基は、鎖状構造であっても、環構造を有していてもよいが、鎖状構造であることが好ましい。炭化水素基が鎖状構造である場合、直鎖状であっても分岐を有していてもよい。
上記炭化水素基としては、アルキル基、アルケニル基、アリール基が好ましく、より好ましくはアルキル基、アルケニル基であり、更に好ましくはアルキル基である。
また、上記炭化水素基の炭素数としては、1〜10が好ましく、より好ましくは1〜8であり、特に好ましくは1〜5であり、特に一層好ましくは1〜2であり、最も好ましくは1である。
上記R1及びR2のうち少なくともいずれか一方は、炭素数1〜12の炭化水素基であることが好ましく、R1及びR2の両方が炭素数1〜12の炭化水素基であることがより好ましい。すなわち、第1〜3級アミノ基の中でも、第3級アミノ基が好ましい。
(In the formula, R 1 and R 2 are the same or different and each represents a hydrogen atom or a hydrocarbon group having 1 to 12 carbon atoms).
The hydrocarbon group may have a chain structure or a ring structure, but preferably has a chain structure. When the hydrocarbon group has a chain structure, it may be linear or branched.
The hydrocarbon group is preferably an alkyl group, an alkenyl group or an aryl group, more preferably an alkyl group or an alkenyl group, and even more preferably an alkyl group.
The number of carbon atoms in the hydrocarbon group is preferably 1-10, more preferably 1-8, particularly preferably 1-5, particularly preferably 1-2, and most preferably 1 Is.
At least one of R 1 and R 2 is preferably a hydrocarbon group having 1 to 12 carbon atoms, and both R 1 and R 2 are hydrocarbon groups having 1 to 12 carbon atoms. More preferable. That is, the tertiary amino group is preferable among the primary to tertiary amino groups.
上記第1〜3級アミノ基の酸による中和物としては、下記式(3); Examples of the neutralized product of the above primary to tertiary amino groups with an acid include the following formula (3);
(式中、R1及びR2は、同一又は異なって、水素原子又は炭素数1〜12の炭化水素基を表す。Y−は、陰イオンを表す。)で表される構造であることが好ましい。炭化水素基の具体例及び好ましい形態は、上述のとおりである。 (In the formula, R 1 and R 2 are the same or different and each represents a hydrogen atom or a hydrocarbon group having 1 to 12 carbon atoms. Y − represents an anion.) preferable. Specific examples and preferable forms of the hydrocarbon group are as described above.
上記カチオン性基含有共重合体は、第1〜3級アミノ基含有単量体(A1)及び/又はこれらの酸による中和物由来の構造単位(a1)の少なくとも1つについて、該構造単位(a1)が有する第2又は3級アミノ基に結合するすべてのアルキル基のそれぞれの炭素数が、上記単量体(B)由来の構造単位(b)の少なくとも1つが有する最も炭素数が多いアルキル基の炭素数よりも少ないものであることが好ましい。
これにより、構造単位(a)と構造単位(b)との疎水性のバランスがより向上し、カビの細胞膜及び細胞壁に対してより効果的に作用する傾向にあるため、本発明の抗カビ剤はより優れた抗カビ性能を発揮することとなる。
上記カチオン性基含有共重合体は、上記の関係を満たす構造単位(a1)(以下、構造単位(a1’)ともいう)と構造単位(b)(以下、構造単位(b’)ともいう)とを少なくとも1つずつ有していればよいが、構造単位(a1’)の割合が、構造単位(a1)100モル%に対して50〜100モル%であることが好ましい。より好ましくは80〜100モル%である。また、上記カチオン性基含有共重合体における構造単位(b’)の割合は、構造単位(b)100モル%に対して50〜100モル%であることが好ましい。より好ましくは80〜100モル%である。
The above-mentioned cationic group-containing copolymer is a structural unit containing at least one structural unit (a1) derived from a neutralized product of a primary to tertiary amino group (A1) and/or an acid thereof. Each of the alkyl groups bonded to the secondary or tertiary amino group of (a1) has the highest number of carbon atoms in at least one of the structural units (b) derived from the monomer (B). It is preferable that the number of carbon atoms is smaller than that of the alkyl group.
As a result, the hydrophobic balance between the structural unit (a) and the structural unit (b) is further improved, and the antifungal agent of the present invention tends to act more effectively on the fungal cell membrane and cell wall. Will exhibit better antifungal performance.
The above-mentioned cationic group-containing copolymer has a structural unit (a1) (hereinafter also referred to as a structural unit (a1′)) and a structural unit (b) (hereinafter also referred to as a structural unit (b′)) satisfying the above relationship. It suffices that each of the structural units (a1′) is 50 to 100 mol %, based on 100 mol% of the structural unit (a1). More preferably, it is 80 to 100 mol %. Further, the proportion of the structural unit (b′) in the cationic group-containing copolymer is preferably 50 to 100 mol% with respect to 100 mol% of the structural unit (b). More preferably, it is 80 to 100 mol %.
上記カチオン性基としては、第1〜3級アミノ基、第1〜3級アミノ基の酸による中和物の中でも、第3級アミノ基、第3級アミノ基の酸による中和物が好ましい。第3級アミノ基又は第3級アミノ基の酸による中和物としてはジメチルアミノ基、ジエチルアミノ基又はこれらの塩酸、酢酸等の酸による中和物が好ましい。 As the above-mentioned cationic group, among the neutralized products of the primary to tertiary amino group and the primary to tertiary amino group with an acid, a tertiary amino group and a neutralized product of the tertiary amino group with an acid are preferable. . As the tertiary amino group or the neutralized product of the tertiary amino group with an acid, a dimethylamino group, a diethylamino group or a neutralized product thereof with an acid such as hydrochloric acid or acetic acid is preferable.
上記カチオン性基含有単量体としては、下記式(4−1)及び/又は(4−2); Examples of the cationic group-containing monomer include the following formulas (4-1) and/or (4-2);
(式(4−1)及び(4−2)中、R5〜R7は、同一又は異なって、水素原子又は炭素数1〜5のアルキル基を表す。Xは、直接結合又は2価の連結基を表す。R3、R4は、上記式(2)におけるR1、R2と同様である。)で表される構造であることが好ましい。 (In formulas (4-1) and (4-2), R 5 to R 7 are the same or different and represent a hydrogen atom or an alkyl group having 1 to 5 carbon atoms. X is a direct bond or a divalent group. It represents a linking group, and R 3 and R 4 are preferably the structures represented by the above formula (2), which are the same as R 1 and R 2 .
上記R7における炭素数1〜5のアルキル基は、メチル基であることが好ましい。上記R7としては、水素原子又はメチル基が好ましい。抗カビ性及び耐加水分解性の観点からR7としてはメチル基がより好ましい。
上記R5、R6は、水素原子であることが好ましい。
The alkyl group having 1 to 5 carbon atoms in R 7 is preferably a methyl group. R 7 is preferably a hydrogen atom or a methyl group. From the viewpoint of antifungal properties and hydrolysis resistance, R 7 is more preferably a methyl group.
The above R 5 and R 6 are preferably hydrogen atoms.
上記式(4−1)及び(4−2)のXにおける2価の連結基としては、特に制限されないが、例えば、炭素数1〜12のアルキレン基や、下記式(5); The divalent linking group for X in the formulas (4-1) and (4-2) is not particularly limited, but examples thereof include an alkylene group having 1 to 12 carbon atoms and the following formula (5);
(式中、mは、0〜12の整数を表す。)、下記式(6); (In the formula, m represents an integer of 0 to 12), the following formula (6);
(式中、eは、0〜4の整数を表す。)及び下記式(7); (In the formula, e represents an integer of 0 to 4) and the following formula (7);
(式中、kは、1〜10の整数を表す。)で表される構造が挙げられる。
上記式(5)におけるmは、1〜8であることが好ましく、より好ましくは1〜5である。
上記式(7)におけるkは、1〜8であることが好ましく、より好ましくは1〜5である。
(In the formula, k represents an integer of 1 to 10.).
M in the above formula (5) is preferably 1 to 8, and more preferably 1 to 5.
K in the above formula (7) is preferably 1 to 8, and more preferably 1 to 5.
上記カチオン性基含有単量体として、具体的には、N,N−ジメチルアミノエチル(メタ)アクリレート、N,N−ジエチルアミノエチル(メタ)アクリレート、N,N−ジメチルアミノプロピル(メタ)アクリレート、N,N−ジエチルアミノプロピル(メタ)アクリレート等のN,N−ジアルキルアミノ基含有(メタ)アクリレート類若しくはこれらの塩酸、酢酸等の酸による中和物;N,N−ジメチルアミノエチル(メタ)アクリルアミド、N,N−ジエチルアミノエチル(メタ)アクリルアミド、N,N−ジメチルアミノプロピル(メタ)アクリルアミド、N,N−ジエチルアミノプロピル(メタ)アクリルアミド等のN,N−ジアルキルアミノ基含有(メタ)アクリルアミド類若しくはこれらの塩酸等の酸による中和物;モノメチルアミノエチル(メタ)アクリレート、モノエチルアミノエチル(メタ)アクリレート、モノメチルアミノプロピル(メタ)アクリレート、モノエチルアミノプロピル(メタ)アクリレート、(メタ)アクリル酸2−(tert−ブチルアミノ)エチル等のモノアルキルアミノ基含有(メタ)アクリレート類及びこれらの塩酸等の酸による中和物;モノメチルアミノエチル(メタ)アクリルアミド、モノエチルアミノエチル(メタ)アクリルアミド、モノメチルアミノプロピル(メタ)アクリルアミド、モノエチルアミノプロピル(メタ)アクリルアミド等のモノアルキルアミノ基含有(メタ)アクリルアミド類及びこれらの塩酸等の酸による中和物;(メタ)アクリル酸−2−アミノエチル等の(メタ)アクリル酸とアルカノールアミンとのエステル類及びこれらの塩酸等の酸による中和物;アリルアミン及びこれの塩酸等の酸による中和物;1−アリルオキシ−3−ジブチルアミノ−2−オール、1−アリルオキシ−3−ジエタノールアミノ−2−オール等の炭素数2〜8の環状エーテル含有基を有する不飽和単量体と炭素数1〜24のアミン化合物との付加反応物若しくはこれの塩酸等の酸による中和物等が挙げられる。 As the cationic group-containing monomer, specifically, N,N-dimethylaminoethyl (meth)acrylate, N,N-diethylaminoethyl (meth)acrylate, N,N-dimethylaminopropyl (meth)acrylate, N,N-dialkylaminopropyl (meth)acrylate-containing N,N-dialkylamino group-containing (meth)acrylates or their neutralized products with acids such as hydrochloric acid and acetic acid; N,N-dimethylaminoethyl (meth)acrylamide , N,N-diethylaminoethyl(meth)acrylamide, N,N-dimethylaminopropyl(meth)acrylamide, N,N-dialkylaminopropyl(meth)acrylamide, or other N,N-dialkylamino group-containing (meth)acrylamides, or Neutralized products of these acids such as hydrochloric acid; monomethylaminoethyl (meth)acrylate, monoethylaminoethyl (meth)acrylate, monomethylaminopropyl (meth)acrylate, monoethylaminopropyl (meth)acrylate, (meth)acrylic acid Monoalkylamino group-containing (meth)acrylates such as 2-(tert-butylamino)ethyl and their neutralized products with acids such as hydrochloric acid; monomethylaminoethyl (meth)acrylamide, monoethylaminoethyl (meth)acrylamide, Monoalkylamino group-containing (meth)acrylamides such as monomethylaminopropyl (meth)acrylamide and monoethylaminopropyl (meth)acrylamide and their neutralized products with acids such as hydrochloric acid; (meth)acrylic acid-2-aminoethyl And the like, esters of (meth)acrylic acid and alkanolamine and their neutralized products with acids such as hydrochloric acid; allylamine and its neutralized products with acids such as hydrochloric acid; 1-allyloxy-3-dibutylamino-2- An addition reaction product of an unsaturated monomer having a cyclic ether-containing group having 2 to 8 carbon atoms such as ol and 1-allyloxy-3-diethanolamino-2-ol with an amine compound having 1 to 24 carbon atoms, or an addition reaction product thereof. Examples include neutralized products with acids such as hydrochloric acid.
上記炭素数1〜24のアミン化合物は、アミノ基を有し、炭素数2〜8の環状エーテル含有基を有する不飽和単量体の環状エーテル構造と反応することができる限り特に制限されない。炭素数1〜24のアミン化合物の炭素数は、1〜20が好ましく、1〜16がより好ましい。炭素数1〜24のアミン化合物としては、第1級アミン、第2級アミンが挙げられ、例えば、炭素数1〜24の(ジ)アルキルアミン、炭素数1〜24の(ジ)アルカノールアミン、炭素数1〜24のアルキルアルカノールアミン等が挙げられる。
炭素数1〜24の(ジ)アルキルアミンとしては、メチルアミン、エチルアミン、プロピルアミン、ブチルアミン、ジメチルアミン、ジエチルアミン、ジプロピルアミン、ジブチルアミン、ペンチルアミン、ジペンチルアミン、ヘキシルアミン、ジヘキシルアミン、ヘプチルアミン、ジヘプチルアミン、オクチルアミン、ジオクチルアミン、ドデシルアミン、ジドデシルアミン等が好ましい。
炭素数1〜24の(ジ)アルカノールアミンとしては、メタノールアミン、エタノールアミン、プロパノールアミン、ブタノールアミン、ジメタノールアミン、ジエタノールアミン、ジプロパノールアミン、ジブタノールアミン、ヘキサノールアミン等が好ましい。
炭素数1〜24のアルキルアルカノールアミンとしては、メチルエタノールアミン等が好ましい。
The amine compound having 1 to 24 carbon atoms is not particularly limited as long as it has an amino group and can react with a cyclic ether structure of an unsaturated monomer having a cyclic ether containing group having 2 to 8 carbon atoms. 1-20 are preferable and, as for carbon number of a C1-C24 amine compound, 1-16 are more preferable. Examples of the amine compound having 1 to 24 carbon atoms include primary amines and secondary amines. For example, (di)alkylamine having 1 to 24 carbon atoms, (di)alkanolamine having 1 to 24 carbon atoms, Examples thereof include alkylalkanolamines having 1 to 24 carbon atoms.
Examples of the (di)alkylamine having 1 to 24 carbon atoms include methylamine, ethylamine, propylamine, butylamine, dimethylamine, diethylamine, dipropylamine, dibutylamine, pentylamine, dipentylamine, hexylamine, dihexylamine, heptylamine. , Diheptylamine, octylamine, dioctylamine, dodecylamine, didodecylamine and the like are preferable.
As the (di)alkanolamine having 1 to 24 carbon atoms, methanolamine, ethanolamine, propanolamine, butanolamine, dimethanolamine, diethanolamine, dipropanolamine, dibutanolamine, hexanolamine and the like are preferable.
As the alkylalkanolamine having 1 to 24 carbon atoms, methylethanolamine and the like are preferable.
上記式(4−1)〜(4−2)のXにおける2価の連結基としては、上記式(5)で表される構造が好ましい。
上記カチオン性基含有単量体は上記式(4−1)及び(4−2)におけるR7が、メチル基であり、Xが、上記式(5)で表される構造であることが好ましい。
The structure represented by the above formula (5) is preferable as the divalent linking group for X in the above formulas (4-1) to (4-2).
In the above-mentioned cationic group-containing monomer, R 7 in the above formulas (4-1) and (4-2) is preferably a methyl group, and X is preferably a structure represented by the above formula (5). ..
上記カチオン性基含有単量体として、好ましくは、N,N−ジアルキルアミノ基含有(メタ)アクリレート類及びこれらの塩酸等の酸による中和物やこれらに4級化剤を付加させたモノマー、N,N−ジアルキルアミノ基含有(メタ)アクリルアミド類及びこれらの塩酸等の酸による中和物、中でもN,N−ジメチルアミノエチル(メタ)アクリレート、N,N−ジエチルアミノエチル(メタ)アクリレート、N,N−ジメチルアミノプロピル(メタ)アクリルアミド及びこれらの塩酸等の酸による中和物がより好ましい。更に好ましくは、N,N−ジエチルアミノエチル(メタ)アクリレート及びこれらの塩酸等の酸による中和物である。 The cationic group-containing monomer is preferably N,N-dialkylamino group-containing (meth)acrylates and their neutralized products with an acid such as hydrochloric acid, or a monomer obtained by adding a quaternizing agent to these. N,N-dialkylamino group-containing (meth)acrylamides and their neutralized products with acids such as hydrochloric acid, among them, N,N-dimethylaminoethyl (meth)acrylate, N,N-diethylaminoethyl (meth)acrylate, N , N-dimethylaminopropyl(meth)acrylamide and neutralized products thereof with an acid such as hydrochloric acid are more preferable. More preferred are N,N-diethylaminoethyl (meth)acrylate and their neutralized products with acids such as hydrochloric acid.
<単量体(B)>
上記単量体(B)は、単独重合を行って得られた単独重合体(ホモポリマー)に対する溶解性パラメータが10以下である単量体(B1)、並びに、カルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有する単量体(B2)、から選択される1種以上の単量体である。なお、単量体(B)にはカチオン性基含有単量体(A)に該当するものは含まれない。また、溶解性パラメータが10以下である単量体であってもカルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有するものは単量体(B2)に分類するものとする。
ここで、上記溶解性パラメータは、「POLYMER ENGINEERING AND SCIENCE」(1974年、Vol.14、No.2)の147〜154ページに記載の方法によって計算される値である。
以下にその方法を概説する。単独重合体の溶解性パラメータ(δ)(cal/cm3)1/2は、該重合体を形成している構成単位の蒸発エネルギー(△ei)及びモル体積(△vi)に基づいて、下記の計算法により算出される。
δ=(△ei/△vi)1/2 (cal/cm3)1/2
<Monomer (B)>
The monomer (B) is a monomer (B1) having a solubility parameter of 10 or less with respect to a homopolymer (homopolymer) obtained by homopolymerization, and a carboxyl group, a hydroxyl group and an ether group. One or more monomers selected from the monomer (B2) having at least one functional group selected from the group consisting of: The monomer (B) does not include the monomer corresponding to the cationic group-containing monomer (A). Further, even a monomer having a solubility parameter of 10 or less is classified as a monomer (B2) if it has at least one functional group selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group. I shall.
Here, the solubility parameter is a value calculated by the method described on pages 147 to 154 of “POLYMER ENGINEERING AND SCIENCE” (1974, Vol. 14, No. 2).
The method is outlined below. The solubility parameter (δ) (cal/cm 3 ) 1/2 of the homopolymer is as follows based on the evaporation energy (Δei) and the molar volume (Δvi) of the structural units forming the polymer. It is calculated by the calculation method of.
δ=(Δei/Δvi) 1/2 (cal/cm 3 ) 1/2
本発明の共重合体が、カチオン性基含有単量体(A)由来の構造単位(a)と上記のような単量体(B)由来の構造単位(b)とを有することにより、カビの細胞膜若しくは細胞壁に対する親和性が向上し、細胞膜若しくは細胞壁との相互作用が増大することで、細胞膜若しくは細胞壁の生理活性にダメージを与えるため、抗カビ性能に優れることとなる。 When the copolymer of the present invention has the structural unit (a) derived from the cationic group-containing monomer (A) and the structural unit (b) derived from the above monomer (B), Since the affinity for the cell membrane or cell wall is improved and the interaction with the cell membrane or cell wall is increased, the physiological activity of the cell membrane or cell wall is damaged, resulting in excellent antifungal performance.
上記単量体(B1)の溶解性パラメータとして好ましくは10以下であり、上記溶解性パラメータとしては通常5以上である。 The solubility parameter of the monomer (B1) is preferably 10 or less, and the solubility parameter is usually 5 or more.
上記単量体(B1)としては、単独重合体での溶解性パラメータが10以下であれば特に制限されないが、(メタ)アクリル酸とカルボキシル基、水酸基及びエーテル基以外の置換基を有していてもよいアルコールとのエステル((メタ)アクリレート)類;スチレン等の芳香族ビニル系単量体;エチレン、プロピレン等のオレフィン系単量体;酢酸ビニル等の不飽和アルコールとカルボン酸とのエステル;塩化ビニル等のハロゲン化ビニル;が挙げられる。
上記単量体(B1)としては、上に挙げた単量体のうち、少なくとも1種類以上を含むことが好ましい。
上記単量体(B1)としては、溶解性パラメータが10以下のものの中でも、炭素数が2以上のアルキル基を有するものが好ましい。単量体(B1)が、炭素数2以上のアルキル基を有することにより、カビの細胞膜若しくは細胞壁との親和性が増し、抗カビ性がより向上する。
The monomer (B1) is not particularly limited as long as the solubility parameter in a homopolymer is 10 or less, but it has (meth)acrylic acid and a substituent other than a carboxyl group, a hydroxyl group and an ether group. Esters with alcohols ((meth)acrylates); aromatic vinyl monomers such as styrene; olefin monomers such as ethylene and propylene; esters of unsaturated alcohols such as vinyl acetate with carboxylic acids A vinyl halide such as vinyl chloride;
As the above-mentioned monomer (B1), it is preferable to include at least one kind or more of the above-mentioned monomers.
As the monomer (B1), those having an alkyl group having 2 or more carbon atoms are preferable among those having a solubility parameter of 10 or less. When the monomer (B1) has an alkyl group having 2 or more carbon atoms, the affinity for the fungal cell membrane or cell wall is increased, and the antifungal property is further improved.
上記(メタ)アクリレートにおけるカルボキシル基、水酸基及びエーテル基以外の置換基としては、例えばフルオロ基等のハロゲノ基等が挙げられる。 Examples of the substituent other than the carboxyl group, the hydroxyl group and the ether group in the (meth)acrylate include a halogeno group such as a fluoro group.
上記のような置換基を有しないアルキル(メタ)アクリレートとしては、例えば、メチル(メタ)アクリレート、エチル(メタ)アクリレート、n−プロピル(メタ)アクリレート、イソプロピル(メタ)アクリレート、n−ブチル(メタ)アクリレート、イソブチル(メタ)アクリレート、tert−ブチル(メタ)アクリレート、sec−ブチル(メタ)アクリレート、2−エチルヘキシル(メタ)アクリレート、n−オクチル(メタ)アクリレート、トリデシル(メタ)アクリレート、シクロヘキシル(メタ)アクリレート等のシクロアルキル(メタ)アクリレート、n−ラウリル(メタ)アクリレート、ドデシル(メタ)アクリレート、ステアリル(メタ)アクリレート、イソボルニルメタクリレート等が挙げられる。 Examples of the alkyl (meth)acrylate having no substituent as described above include, for example, methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth). ) Acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, sec-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, n-octyl (meth)acrylate, tridecyl (meth)acrylate, cyclohexyl (meth) ) Cycloalkyl (meth)acrylates such as acrylate, n-lauryl (meth)acrylate, dodecyl (meth)acrylate, stearyl (meth)acrylate, isobornyl methacrylate and the like.
フルオロ基含有(メタ)アクリレートとしては、例えば、トリフルオロエチル(メタ)アクリレート、テトラフルオロプロピル(メタ)アクリレート、オクタフルオロペンチル(メタ)アクリレートなどのエステル基の炭素数が2〜6のフルオロ基含有アルキル(メタ)アクリレート等が挙げられる。 Examples of the fluoro group-containing (meth)acrylate include a fluoro group having a carbon number of 2 to 6 in the ester group such as trifluoroethyl (meth)acrylate, tetrafluoropropyl (meth)acrylate, octafluoropentyl (meth)acrylate and the like. Alkyl (meth)acrylate etc. are mentioned.
上記単量体(B1)は、少なくとも1種の(メタ)アクリル酸エステルを含むことが好ましい。
上記(メタ)アクリル酸エステルとしては、下記式(8);
The monomer (B1) preferably contains at least one (meth)acrylic acid ester.
The above (meth)acrylic acid ester has the following formula (8);
(式中、R8は、水素原子又はメチル基を表す。R9は、炭素数1〜30の炭化水素基を表す。)で表される化合物であることが好ましい。
上記炭化水素基の炭素数は、1〜20であることが好ましい。より好ましくは1〜16であり、更に好ましくは2〜12であり、一層好ましくは2〜8であり、特に好ましくは2〜4である。
上記炭化水素基の炭素数が1〜20であれば、重合体の水溶性、粘度を好適な範囲とすることができ、取扱いに優れるものとなる。上記炭化水素基の炭素数が2〜12であれば、重合体の製造が容易となり、さらに、抗カビ性に加えて安全性にも優れるものとなる。さらに上記炭化水素基の炭素数が2〜4であれば、重合体の製造が容易であるだけでなく、安全性に優れ、かつカビの細胞膜若しくは細胞壁との親和性が増し、抗カビ性がより向上するものとなる。
(In the formula, R 8 represents a hydrogen atom or a methyl group, and R 9 represents a hydrocarbon group having 1 to 30 carbon atoms).
The hydrocarbon group preferably has 1 to 20 carbon atoms. It is more preferably 1-16, still more preferably 2-12, even more preferably 2-8, and particularly preferably 2-4.
When the number of carbon atoms in the hydrocarbon group is 1 to 20, the water solubility and viscosity of the polymer can be set within a suitable range, and handling becomes excellent. When the number of carbon atoms in the hydrocarbon group is 2 to 12, the production of the polymer becomes easy and, in addition to the antifungal property, the polymer also becomes excellent in safety. Further, when the number of carbon atoms of the above hydrocarbon group is 2 to 4, not only the production of the polymer is easy, but also the safety is excellent, and the affinity for the fungal cell membrane or cell wall is increased, and the antifungal property is increased. It will be improved.
上記炭化水素基としては、特に制限されず、アルキル基、アルケニル基、アルキニル基等の鎖状炭化水素基、芳香族炭化水素基、シクロアルキル基、シクロアルケニル基等の環状炭化水素基が挙げられる。上記炭化水素基は、分岐を有していてもよく、分岐を有する場合の炭化水素基の炭素数は、主鎖及び分岐鎖の合計の炭素数を意味する。
上記アルキル基としては、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、t−ブチル基、ペンチル基、ヘキシル基、ヘプチル基、2−エチルへキシル基、オクチル基、ノニル基、デシル基、ドデシル(ラウリル)基、ステアリル基、イコシル基等が挙げられる。
上記アルケニル基としては、例えば、ビニル基、アリル基、1−ブテニル基、2−ブテニル基、ペンテニル基、ヘキセニル基、ヘプテニル基、オクテニル基、ノネニル基、デセニル基、ドデセニル基、オクタデセニル基、イコセニル基等が挙げられる。
上記アルキニル基としては、例えば、エチニル基、1−プロピニル基、2−プロピニル基、ブチニル基、ペンチニル基、ヘキシニル基、ヘプチニル基、オクチニル基、ノニニル基、デシニル基、ドデシニル基、オクタデシニル基、イコシニル基等が挙げられる。
The hydrocarbon group is not particularly limited, and examples thereof include chain hydrocarbon groups such as alkyl groups, alkenyl groups, and alkynyl groups, aromatic hydrocarbon groups, cyclic hydrocarbon groups such as cycloalkyl groups, and cycloalkenyl groups. .. The hydrocarbon group may have a branch, and the carbon number of the hydrocarbon group in the case of having a branch means the total carbon number of the main chain and the branched chain.
Examples of the alkyl group include, for example, methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, t-butyl group, pentyl group, hexyl group, heptyl group, 2-ethylhexyl group, octyl group, Examples thereof include nonyl group, decyl group, dodecyl (lauryl) group, stearyl group and icosyl group.
Examples of the alkenyl group include vinyl group, allyl group, 1-butenyl group, 2-butenyl group, pentenyl group, hexenyl group, heptenyl group, octenyl group, nonenyl group, decenyl group, dodecenyl group, octadecenyl group, icosenyl group. Etc.
As the alkynyl group, for example, ethynyl group, 1-propynyl group, 2-propynyl group, butynyl group, pentynyl group, hexynyl group, heptynyl group, octynyl group, nonynyl group, decynyl group, dodecynyl group, octadecynyl group, icosinyl group. Etc.
上記芳香族炭化水素基としては、例えば、フェニル基、ベンジル基、トリル基、o−キシリル基等が挙げられる。
上記シクロアルキル基としては、例えば、シクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基等が挙げられる。
上記シクロアルケニル基としては、例えば、シクロプロペニル基、シクロブテニル基、シクロペンテニル基、シクロヘキセニル基等が挙げられる。
上記炭化水素基として、好ましくはアルキル基、アルケニル基であり、より好ましくはアルキル基である。
すなわち上記(メタ)アクリル酸エステルとしては、(メタ)アクリル酸アルキルエステル(アルキル(メタ)アクリレート)が好ましい。
Examples of the aromatic hydrocarbon group include a phenyl group, a benzyl group, a tolyl group, and an o-xylyl group.
Examples of the cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and the like.
Examples of the cycloalkenyl group include a cyclopropenyl group, a cyclobutenyl group, a cyclopentenyl group, a cyclohexenyl group and the like.
The above hydrocarbon group is preferably an alkyl group or an alkenyl group, more preferably an alkyl group.
That is, as the (meth)acrylic acid ester, a (meth)acrylic acid alkyl ester (alkyl(meth)acrylate) is preferable.
アルキル(メタ)アクリレートとして好ましくはメチル(メタ)アクリレート、エチル(メタ)アクリレート、n−プロピル(メタ)アクリレート、イソプロピル(メタ)アクリレート、n−ブチル(メタ)アクリレート、イソブチル(メタ)アクリレート、tert−ブチル(メタ)アクリレート、sec−ブチル(メタ)アクリレート、2−エチルヘキシル(メタ)アクリレート、n−オクチル(メタ)アクリレートであり、より好ましくは、メチル(メタ)アクリレート、エチル(メタ)アクリレート、n−プロピル(メタ)アクリレート、イソプロピル(メタ)アクリレート、n−ブチル(メタ)アクリレート、イソブチル(メタ)アクリレート、tert−ブチル(メタ)アクリレート、sec−ブチル(メタ)アクリレート、2−エチルヘキシル(メタ)アクリレートであり、更に好ましくはエチル(メタ)アクリレート、n−ブチル(メタ)アクリレート、イソブチル(メタ)アクリレート、tert−ブチル(メタ)アクリレート、sec−ブチル(メタ)アクリレートであり、一層好ましくはエチル(メタ)アクリレート、イソブチル(メタ)アクリレート、tert−ブチル(メタ)アクリレートであり、特に好ましくはエチルメタクリレート、イソブチルアクリレート、tert−ブチルアクリレートである。 The alkyl(meth)acrylate is preferably methyl(meth)acrylate, ethyl(meth)acrylate, n-propyl(meth)acrylate, isopropyl(meth)acrylate, n-butyl(meth)acrylate, isobutyl(meth)acrylate, tert-. Butyl (meth) acrylate, sec-butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, n-octyl (meth) acrylate, more preferably methyl (meth) acrylate, ethyl (meth) acrylate, n-. Propyl (meth)acrylate, isopropyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, sec-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate Yes, more preferably ethyl (meth)acrylate, n-butyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, sec-butyl (meth)acrylate, and even more preferably ethyl (meth). Acrylate, isobutyl (meth)acrylate, and tert-butyl (meth)acrylate are preferable, and ethyl methacrylate, isobutyl acrylate, and tert-butyl acrylate are particularly preferable.
上記単量体(B2)は、カルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有するものであれば特に制限されず、これらの官能基を2種以上有するものであってもよい。例えばカルボキシル基を有する単量体が、水酸基やエーテル基を有するものであってもよい。
カルボキシル基を有する単量体としては、例えば、(メタ)アクリル酸、クロトン酸、α−アリルオキシアクリル酸及びこれらの塩等の不飽和モノカルボン酸類;マレイン酸、イタコン酸、メサコン酸、シトラコン酸、フマル酸及びこれらの塩等の不飽和ジカルボン酸類;アクリル酸2−カルボキシエチル等のカルボキシル基含有(メタ)アクリレート等が挙げられる。これらの中でも不飽和モノカルボン酸類が好ましく、より好ましくは(メタ)アクリル酸である。上記不飽和モノカルボン酸の塩としては、金属塩が挙げられる。上記金属塩の金属としては、リチウム、ナトリウム、カリウム等のアルカリ金属、亜鉛等の重金属塩が挙げられる。
The monomer (B2) is not particularly limited as long as it has at least one kind of functional group selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group, and has two or more kinds of these functional groups. May be For example, the monomer having a carboxyl group may have a hydroxyl group or an ether group.
Examples of the monomer having a carboxyl group include unsaturated monocarboxylic acids such as (meth)acrylic acid, crotonic acid, α-allyloxyacrylic acid and salts thereof; maleic acid, itaconic acid, mesaconic acid, citraconic acid. Unsaturated dicarboxylic acids such as fumaric acid and salts thereof; and carboxyl group-containing (meth)acrylates such as 2-carboxyethyl acrylate. Among these, unsaturated monocarboxylic acids are preferable, and (meth)acrylic acid is more preferable. Examples of the unsaturated monocarboxylic acid salt include metal salts. Examples of the metal of the metal salt include alkali metals such as lithium, sodium and potassium, and heavy metal salts such as zinc.
水酸基を有する単量体としては、例えば、上記ビニルアルコール、アリルアルコール、イソプレニルアルコール等の炭素数2〜20の不飽和アルコール類;2−ヒドロキシエチル(メタ)アクリレート、2−ヒドロキシプロピル(メタ)アクリレート、3−ヒドロキシプロピル(メタ)アクリレート、2−ヒドロキシブチル(メタ)アクリレート、4−ヒドロキシブチル(メタ)アクリレートなどのエステル基の炭素数が1〜18の水酸基含有(メタ)アクリレート等が挙げられる。これらの中でも水酸基含有(メタ)アクリレートが好ましく、より好ましくは2−ヒドロキシエチル(メタ)アクリレートである。 Examples of the monomer having a hydroxyl group include unsaturated alcohols having 2 to 20 carbon atoms such as the above-mentioned vinyl alcohol, allyl alcohol, and isoprenyl alcohol; 2-hydroxyethyl (meth)acrylate, 2-hydroxypropyl (meth). Examples thereof include a hydroxyl group-containing (meth)acrylate having an ester group having 1 to 18 carbon atoms such as acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxybutyl (meth)acrylate, and 4-hydroxybutyl (meth)acrylate. .. Of these, a hydroxyl group-containing (meth)acrylate is preferable, and 2-hydroxyethyl (meth)acrylate is more preferable.
エーテル基を有する単量体としては、例えば、メトキシエチル(メタ)アクリレート、メトキシプロピル(メタ)アクリレート、メトキシブチル(メタ)アクリレート、エトキシブチル(メタ)アクリレート、トリメチロールプロパントリプロポキシ(メタ)アクリレート等のアルコキシアルキル(メタ)アクリレート;エチレングリコール(メタ)アクリレート、エチレングリコールメトキシ(メタ)アクリレート、ジエチレングリコール(メタ)アクリレート、ジエチレングリコールメトキシ(メタ)アクリレート等の(ジ)エチレングリコール(メトキシ)(メタ)アクリレート;アルコキシポリエチレングリコールメタクリレート(アントックスLMA−10)等のアルキレングリコールの繰り返し数が1〜100のアルコキシポリアルキレングリコール(メタ)アクリレート;グリシジル(メタ)アクリレート、α−メチルグリシジル(メタ)アクリレート、グリシジルアリルエーテル等のエポキシ基含有(メタ)アクリレート;メチルビニルエーテル、エチルビニルエーテル等のアルキルビニルエーテル類;アリルアルコールのエチレンオキシド付加物の末端疎水変性物、メタリルアルコールのエチレンオキシド付加物の末端疎水変性物、イソプレノールのエチレンオキシド付加物等の炭素数2〜20の不飽和アルコールのアルキレンオキシド付加物の末端疎水変性物;等が挙げられる。これらの中でもエーテル基を1つ有する単量体が好ましい。 Examples of the monomer having an ether group include methoxyethyl (meth)acrylate, methoxypropyl (meth)acrylate, methoxybutyl (meth)acrylate, ethoxybutyl (meth)acrylate, and trimethylolpropane tripropoxy (meth)acrylate. Alkoxyalkyl (meth)acrylates; ethylene glycol (meth)acrylates, ethylene glycol methoxy (meth)acrylates, diethylene glycol (meth)acrylates, diethylene glycol methoxy (meth)acrylates and other (di)ethylene glycol (methoxy)(meth)acrylates; Alkoxypolyalkylene glycol (meth)acrylate in which the number of repeating alkylene glycols such as alkoxypolyethylene glycol methacrylate (ANTOX LMA-10) is 1 to 100; glycidyl (meth)acrylate, α-methylglycidyl (meth)acrylate, glycidyl allyl ether. Epoxy group-containing (meth)acrylates such as; alkyl vinyl ethers such as methyl vinyl ether and ethyl vinyl ether; end-hydrophobic modified products of ethylene oxide adducts of allyl alcohol; End-hydrophobic modified products of alkylene oxide adducts of unsaturated alcohols having 2 to 20 carbon atoms. Among these, a monomer having one ether group is preferable.
単量体(B2)として好ましくは、カルボキシル基及び/又は水酸基を有する単量体が好ましい。より好ましくはカルボキシル基を有する単量体(以下、カルボキシル基含有単量体(B2−1)ともいう。)である。
カチオン性基含有共重合体がカルボキシル基含有単量体(B2−1)に由来する構造単位(b2−1)を有する形態は本発明の好適な実施形態の1つである。カチオン性基含有共重合体が、カルボキシル基含有単量体(B2−1)に由来する構造単位(b2−1)を有する場合、該構造単位(b2−1)を全構造単位100質量%に対して1.0〜30質量%の割合で有することが好ましい。より好ましくは1.0〜20質量%であり、特に好ましくは1.0〜10質量%の割合である。
As the monomer (B2), a monomer having a carboxyl group and/or a hydroxyl group is preferable. More preferably, it is a monomer having a carboxyl group (hereinafter, also referred to as a carboxyl group-containing monomer (B2-1)).
The form in which the cationic group-containing copolymer has the structural unit (b2-1) derived from the carboxyl group-containing monomer (B2-1) is one of the preferred embodiments of the present invention. When the cationic group-containing copolymer has a structural unit (b2-1) derived from a carboxyl group-containing monomer (B2-1), the structural unit (b2-1) is added to 100% by mass of all structural units. On the other hand, it is preferable to have the ratio of 1.0 to 30 mass %. It is more preferably 1.0 to 20% by mass, and particularly preferably 1.0 to 10% by mass.
本発明の抗カビ剤に含まれるカチオン性基含有共重合体(以下、本発明の共重合体ともいう)はまた、単量体(B)として、(メタ)アクリル酸アルキルエステル由来の構造単位を有し、更にカルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有する単量体(B2)由来の構造単位とを有するものであることが好ましい。このような構造単位を有する共重合体もまた、本発明の好適な実施形態の1つである。
本発明において、単量体(B)として、上記(メタ)アクリル酸アルキルエステルとカルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有する単量体(B2)とを共重合することにより、得られる共重合体の水溶性が向上し、また、塩やpHによる共重合体の析出、抗カビ性の低下等の影響をより充分に緩和することができるため、幅広いpH領域において共重合体を使用することができ、弱酸性のものが多い化粧品や、中性から弱アルカリ領域のものが多い洗剤等の種々の用途に好適に用いることができる。
The cationic group-containing copolymer contained in the antifungal agent of the present invention (hereinafter, also referred to as the copolymer of the present invention) also has, as the monomer (B), a structural unit derived from a (meth)acrylic acid alkyl ester. And a structural unit derived from the monomer (B2) having at least one functional group selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group. A copolymer having such a structural unit is also one of the preferred embodiments of the present invention.
In the present invention, as the monomer (B), a monomer (B2) having the above (meth)acrylic acid alkyl ester and at least one functional group selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group, By copolymerizing the above, the water solubility of the resulting copolymer is improved, and the precipitation of the copolymer due to salt or pH, and the effect of reducing antifungal properties, etc. can be more sufficiently alleviated. The copolymer can be used in a wide pH range and can be suitably used for various applications such as cosmetics, which are often weakly acidic, and detergents, which are often neutral to weakly alkaline.
<その他の単量体>
本発明の共重合体は、必要に応じて、抗カビ性能に影響しない程度に上記カチオン性基含有単量体(A)及び単量体(B)以外のその他の単量体(E)由来の構造単位(e)を有していてもよい。その他の単量体(E)としては、カチオン性基を有しないものであって、カチオン性基含有単量体(A)及び単量体(B)と共重合できるものである限り特に制限されない。
アクリロニトリル、アクリルアミド、N−ビニルピロリドン等の環状ビニル系単量体等が挙げられる。
また、粘度を調整する観点から溶解性パラメータの値や有する官能基の種類に関わらずエチレン性不飽和基を2個以上有する単量体が含まれていてもよい。エチレン性不飽和基を2個以上有する単量体としては、エチレングリコール、プロピレングリコール、ポリオキシエチレングリコール、ポリオキシプロピレングリコール、グリセリン、ポリグリセリン、トリメチロールプロパン、ペンタエリスリトール、サッカロース、ソルビトール、1,4−ブタンジオール等のポリオールの2置換以上の水酸基と(メタ)アクリル酸とのエステル類;上記ポリオールの2置換以上のメタクリル酸エステル類;フタル酸ジアリル、リン酸トリアリル、メタクリル酸アリル、テトラアリルオキシエタン、トリアリルシアヌレート、アジピン酸ジビニル、クロトン酸ビニル、1,5−ヘキサジエン、ジビニルベンゼン等が挙げられる。これらのその他の単量体は、単独で用いてもよく、2種以上を併用してもよい。
<Other monomers>
The copolymer of the present invention is, if necessary, derived from other monomers (E) other than the above-mentioned cationic group-containing monomer (A) and monomer (B) to the extent that they do not affect the antifungal performance. The structural unit (e) may be included. The other monomer (E) is not particularly limited as long as it has no cationic group and can be copolymerized with the cationic group-containing monomer (A) and the monomer (B). ..
Cyclic vinyl monomers such as acrylonitrile, acrylamide, N-vinylpyrrolidone and the like can be mentioned.
Further, from the viewpoint of adjusting the viscosity, a monomer having two or more ethylenically unsaturated groups may be contained regardless of the value of the solubility parameter or the type of the functional group. As the monomer having two or more ethylenically unsaturated groups, ethylene glycol, propylene glycol, polyoxyethylene glycol, polyoxypropylene glycol, glycerin, polyglycerin, trimethylolpropane, pentaerythritol, saccharose, sorbitol, 1, Esters of (meth)acrylic acid with 2- or more-substituted hydroxyl groups of polyols such as 4-butanediol; 2- or more-substituted methacrylic acid esters of the above polyols; diallyl phthalate, triallyl phosphate, allyl methacrylate, tetraallyl Examples thereof include oxyethane, triallyl cyanurate, divinyl adipate, vinyl crotonate, 1,5-hexadiene and divinylbenzene. These other monomers may be used alone or in combination of two or more.
<カチオン性基含有共重合体の製造方法>
本発明の共重合体の製造は特に制限されないが、単量体成分を重合することにより製造することができ、単量体成分の具体例、好ましい例及び各単量体の好ましい割合は、共重合体の組成と同様である。
<Method for producing cationic group-containing copolymer>
The production of the copolymer of the present invention is not particularly limited, but it can be produced by polymerizing a monomer component, and specific examples of the monomer component, preferable examples and preferable ratios of the respective monomers are It is similar to the composition of the polymer.
上記共重合体は、上記単量体成分を重合開始剤の存在下で重合する方法により製造することが好ましい。単量体成分を重合させる際には、重合方法に応じて重合開始剤を適宜用いることができる。上記重合開始剤としては、通常用いられるものを使用することができ、例えば、過酸化水素;過硫酸ナトリウム、過硫酸アンモニウム等の過硫酸塩;ジメチル2,2’−アゾビス(2−メチルプロピオネート)、2,2’−アゾビス(イソブチロニトリル)、2,2’−アゾビス(2−メチルブチロニトリル)、2,2’−アゾビス(イソ酪酸)ジメチル、4,4’−アゾビス(4−シアノ吉草酸)、2,2’−アゾビス(2−メチルプロピオンアミジン)二塩酸塩、2,2’−アゾビス[N−(2−カルボキシエチル)−2−メチルプロピオンアミジン]n水和物、2,2’−アゾビス[2−(2−イミダゾリン−2−イル)プロパン]二塩酸塩、2,2’−アゾビス[2−(2−イミダゾリン−2−イル)プロパン]二硫酸塩二水和物、1,1’−アゾビス(シクロヘキサン−1−カルボニトリル)、2,2’−アゾビス[N−(2−プロペニル)−2−メチルプロピオンアミド]、2,2’−アゾビス(2,4−ジメチルバレロニトリル)等のアゾ系化合物;過酸化ベンゾイル、過酸化ラウロイル、過酢酸、ジ−t−ブチルパーオキサイド等の有機過酸化物等が好適である。これらの重合開始剤のうち、アゾ系化合物が好ましい。上記重合開始剤としては、かかる例示のみに限定されるものではない。これらの重合開始剤は、それぞれ単独で用いてもよく、2種類以上を併用してもよい。 The copolymer is preferably produced by a method of polymerizing the monomer component in the presence of a polymerization initiator. When polymerizing the monomer component, a polymerization initiator can be appropriately used depending on the polymerization method. As the above-mentioned polymerization initiator, those generally used can be used, and examples thereof include hydrogen peroxide; persulfates such as sodium persulfate and ammonium persulfate; dimethyl 2,2′-azobis(2-methylpropionate). ), 2,2′-azobis(isobutyronitrile), 2,2′-azobis(2-methylbutyronitrile), 2,2′-azobis(isobutyric acid)dimethyl, 4,4′-azobis(4 -Cyanovaleric acid), 2,2'-azobis(2-methylpropionamidine) dihydrochloride, 2,2'-azobis[N-(2-carboxyethyl)-2-methylpropionamidine] n hydrate, 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride, 2,2'-azobis[2-(2-imidazolin-2-yl)propane]disulfate dihydrate , 1,1'-azobis(cyclohexane-1-carbonitrile), 2,2'-azobis[N-(2-propenyl)-2-methylpropionamide], 2,2'-azobis(2,4- Azo compounds such as dimethyl valeronitrile); benzoyl peroxide, lauroyl peroxide, peracetic acid, organic peroxides such as di-t-butyl peroxide, and the like are preferable. Of these polymerization initiators, azo compounds are preferable. The above-mentioned polymerization initiator is not limited to these examples. These polymerization initiators may be used alone or in combination of two or more kinds.
上記重合開始剤の使用量は、上記単量体成分の重合を開始できる量であれば特に制限されないが、全単量体成分100質量部に対して、通常0.01〜50質量部であり、好ましくは0.05〜30質量部、より好ましくは0.05〜20質量部であることが好ましい。 The amount of the polymerization initiator used is not particularly limited as long as it can initiate the polymerization of the monomer components, but is usually 0.01 to 50 parts by mass with respect to 100 parts by mass of all the monomer components. It is preferably 0.05 to 30 parts by mass, more preferably 0.05 to 20 parts by mass.
本発明で用いるカチオン性基含有単量体の使用方法としては、それらを酸により中和した酸中和物として用いてもよい。
カチオン性基含有単量体の中和に用いる酸としては、特に制限されるものではないが、塩酸、硫酸等の無機酸;酢酸、クエン酸、酒石酸、トルエンスルホン酸、乳酸、コハク酸、グリコール酸等の有機酸が挙げられる。
The cationic group-containing monomer used in the present invention may be used as an acid neutralized product obtained by neutralizing them with an acid.
The acid used for neutralizing the cationic group-containing monomer is not particularly limited, but inorganic acids such as hydrochloric acid and sulfuric acid; acetic acid, citric acid, tartaric acid, toluenesulfonic acid, lactic acid, succinic acid, glycol Examples thereof include organic acids such as acids.
上記酸を用いる場合、これらの使用量としては、上記カチオン性基含有単量体の一部又は全部が中和又は4級化される限り特に制限されないが、重合反応に用いるカチオン性基含有単量体1規定に対して、酸は0.5〜2.0規定であることが好ましい。より好ましくは0.7〜1.5規定であること、特に好ましくは1.0〜1.2規定である。 When the above-mentioned acid is used, the amount thereof is not particularly limited as long as a part or all of the above-mentioned cationic group-containing monomer is neutralized or quaternized, but the cationic group-containing monomer used in the polymerization reaction is not particularly limited. The acid is preferably 0.5 to 2.0 N relative to 1 N of the monomer. It is more preferably 0.7 to 1.5, and particularly preferably 1.0 to 1.2.
上記共重合方法において、単量体成分や重合開始剤等の反応容器への添加方法としては、反応容器に単量体成分の全てを仕込み、重合開始剤を反応容器内に添加することによって共重合を行う方法;反応容器に単量体成分の一部を仕込み、重合開始剤と残りの単量体成分を反応容器内に連続してあるいは段階的に(好ましくは連続して)添加することによって共重合を行う方法;反応容器に重合溶媒を仕込み、単量体成分と重合開始剤の全量を添加する方法;単量体のうちの一(例えば、カチオン性基含有単量体)の一部を反応容器に仕込み、重合開始剤と残りの単量体成分を反応容器内に(好ましくは連続して)添加することによって共重合を行う方法等が好適である。このような方法の中でも、得られる共重合体の分子量分布を狭く(シャープに)することができうることから、重合開始剤と単量体成分を反応容器に逐次滴下する方法で共重合を行うことが好ましい。 In the above-mentioned copolymerization method, as a method of adding a monomer component, a polymerization initiator and the like to a reaction vessel, all of the monomer components are charged in the reaction vessel, and the polymerization initiator is added to the reaction vessel. Polymerization method: Part of a monomer component is charged into a reaction vessel, and a polymerization initiator and the remaining monomer component are continuously or stepwise (preferably continuously) added into the reaction vessel. Copolymerization method by charging the reaction vessel with a polymerization solvent and adding the total amount of the monomer component and the polymerization initiator; one of the monomers (for example, a cationic group-containing monomer) A method in which a part is charged into a reaction vessel and a polymerization initiator and the remaining monomer components are added (preferably continuously) into the reaction vessel to carry out copolymerization is suitable. Among these methods, it is possible to narrow (sharply) the molecular weight distribution of the obtained copolymer, and thus the copolymerization is carried out by the method of successively dropping the polymerization initiator and the monomer component into the reaction vessel. Preferably.
上記共重合方法としては、例えば、溶液重合やバルク重合、懸濁重合、乳化重合、リビング重合やグラフト重合等の方法で行うことができ、特に限定されるものではないが、溶液重合が好ましい。この際使用できる溶媒は、水単独もしくは水と溶剤との混合溶媒であることが好ましい。水のみを使用する場合には、脱溶剤工程を省略できる点で好適である。 The copolymerization method can be carried out by, for example, solution polymerization, bulk polymerization, suspension polymerization, emulsion polymerization, living polymerization or graft polymerization, and is not particularly limited, but solution polymerization is preferable. The solvent that can be used at this time is preferably water alone or a mixed solvent of water and a solvent. When only water is used, it is preferable because the solvent removal step can be omitted.
上記共重合方法は、回分式でも連続式でも行うことができる。また、共重合の際、必要に応じて使用される溶媒としては、公知のものを使用でき、水;メチルアルコール、エチルアルコール、イソプロピルアルコール、ブタノール、THF(テトラヒドロフラン)等の1価のアルコール類;グリセリン、(ポリ)エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、ジプロピレングリコール等の多価アルコール;ベンゼン、トルエン、キシレン、シクロヘキサン、n−ヘプタン等の芳香族又は脂肪族炭化水素類;酢酸エチル等のエステル類;アセトン、メチルエチルケトン等のケトン類;ジメチルホルムアミド等のアミド類;ジエチルエーテル、ジオキサン等のエーテル類等が好適である。これらは単独で用いてもよく、2種以上を併用してもよい。これらの中でも、単量体成分及び得られる共重合体の溶解性の点から、水及び炭素数1〜4の低級アルコールからなる群より選択される1種又は2種以上の溶媒を用いることが好ましい。上記溶媒は、比較的安価なものであり、本発明の製造方法は、経済的にも優れる。また、上記共重合方法においては、水にプロピレングリコール、1,3−ブチレングリコールやエチレングリコール等の多価アルコール溶媒を加えて重合してもよい。上記多価アルコール溶媒は水と併用することによって、ポリマーの溶解性を高めることができ、ソープフリー重合をより充分に抑制することができる。これにより、水溶性に乏しいポリマーの生成をより充分に抑制し、溶液の透明性をより向上させることができる。上記多価アルコール溶媒と水とを併用する場合、水100質量%に対する多価アルコール溶媒の割合は、0〜200質量%であることが好ましい。
多価アルコール溶媒としてより好ましくは1,3−ブチレングリコールである。
1,3−ブチレングリコールを溶媒として用いた場合、得られる共重合体は、1,3−ブチレングリコールを含むこととなり、この場合、抗カビ性能により優れることとなる。
本発明の抗菌剤が、共重合体100質量%に対して1,3−ブチレングリコールを0〜80質量%含む形態もまた、本発明の好ましい実施形態の1つである。
得られたポリマーは水に任意に溶解するもの、もしくは任意に分散するものどちらでもよいが、水に任意に溶解するものが特に好ましい。本発明の共重合体が、25℃において100gの水に10g溶解させた際の不溶分が1g以下である形態は、本発明の好ましい実施形態の1つである。
本発明の共重合体の製造方法はまた、必要に応じて、任意の連鎖移動剤、pH調節剤、緩衝剤などを用いることもできる。
The above copolymerization method can be carried out batchwise or continuously. Known solvents can be used as necessary in the copolymerization, and water; monohydric alcohols such as methyl alcohol, ethyl alcohol, isopropyl alcohol, butanol, and THF (tetrahydrofuran); Polyhydric alcohols such as glycerin, (poly)ethylene glycol, propylene glycol, 1,3-butylene glycol, dipropylene glycol; aromatic or aliphatic hydrocarbons such as benzene, toluene, xylene, cyclohexane, n-heptane; acetic acid Preferred are esters such as ethyl; ketones such as acetone and methyl ethyl ketone; amides such as dimethylformamide; ethers such as diethyl ether and dioxane. These may be used alone or in combination of two or more. Among these, one or two or more solvents selected from the group consisting of water and a lower alcohol having 1 to 4 carbon atoms may be used from the viewpoint of solubility of the monomer component and the copolymer obtained. preferable. The solvent is relatively inexpensive and the production method of the present invention is economically excellent. In the above-mentioned copolymerization method, a polyhydric alcohol solvent such as propylene glycol, 1,3-butylene glycol or ethylene glycol may be added to water for polymerization. When the polyhydric alcohol solvent is used in combination with water, the solubility of the polymer can be increased, and soap-free polymerization can be more sufficiently suppressed. This makes it possible to more sufficiently suppress the production of a polymer having poor water solubility and further improve the transparency of the solution. When the polyhydric alcohol solvent and water are used in combination, the ratio of the polyhydric alcohol solvent to 100% by mass of water is preferably 0 to 200% by mass.
The polyhydric alcohol solvent is more preferably 1,3-butylene glycol.
When 1,3-butylene glycol is used as a solvent, the obtained copolymer contains 1,3-butylene glycol, and in this case, it is more excellent in antifungal performance.
A form in which the antibacterial agent of the present invention contains 0 to 80% by mass of 1,3-butylene glycol based on 100% by mass of the copolymer is also one of preferred embodiments of the present invention.
The polymer obtained may be either one that is freely soluble in water or one that is optionally dispersed, but one that is freely soluble in water is particularly preferred. It is one of the preferred embodiments of the present invention that the copolymer of the present invention has an insoluble content of 1 g or less when dissolved in 10 g of 100 g of water at 25°C.
In the method for producing the copolymer of the present invention, any chain transfer agent, pH adjusting agent, buffering agent or the like can be used, if necessary.
重合の際の温度は特に限定されないが、通常50〜120℃であり、好ましくは60〜110℃である。重合時の温度が上記範囲であれば、残存単量体成分が少なくなる傾向にある。なお、重合時の温度は、重合反応の進行中において、常に一定に保持する必要はなく、例えば、室温から重合を開始し、適当な昇温時間又は昇温速度で設定温度まで昇温し、その後、設定温度を保持するようにしてもよいし、単量体成分や開始剤等の滴下方法に応じて、重合反応の進行中に経時的に重合温度を変動(昇温又は降温)させてもよい。また、単量体成分を重合させる際には、単量体成分が均一に重合するようにするために、適宜、撹拌することが好ましい。 The temperature at the time of polymerization is not particularly limited, but is usually 50 to 120°C, preferably 60 to 110°C. When the temperature at the time of polymerization is in the above range, the residual monomer component tends to decrease. The temperature during the polymerization does not always have to be kept constant during the progress of the polymerization reaction, and for example, the polymerization is started from room temperature and the temperature is raised to a set temperature at an appropriate heating time or heating rate, After that, the set temperature may be maintained, or the polymerization temperature may be changed (increased or decreased) with time during the progress of the polymerization reaction, depending on the dropping method of the monomer component, the initiator and the like. Good. Further, when the monomer component is polymerized, it is preferable to appropriately stir so that the monomer component is uniformly polymerized.
重合時間は特に制限されず、重合反応の進行状況に応じて適宜設定すればよいが、通常、2〜9時間程度である。
なお、本発明において、「重合時間」とは単量体の滴下前の加熱撹拌を行っている時間、単量体を添加している時間及び単量体の滴下後の熟成時間を表す。
The polymerization time is not particularly limited and may be appropriately set depending on the progress of the polymerization reaction, but is usually about 2 to 9 hours.
In addition, in this invention, "polymerization time" represents the time which heat-stirs before dropping of a monomer, the time of adding a monomer, and the aging time after dropping of a monomer.
反応系内の圧力としては、常圧(大気圧)下、減圧下、加圧下のいずれであってもよい。反応系内の雰囲気としては、空気雰囲気でも不活性雰囲気でもどちらでもよい。 The pressure in the reaction system may be normal pressure (atmospheric pressure), reduced pressure, or increased pressure. The atmosphere in the reaction system may be either an air atmosphere or an inert atmosphere.
上記重合反応系における重合反応が終了した時点での水溶液中の固形分濃度(すなわち単量体の重合固形分濃度)は、20質量%以上が好ましく、25〜80質量%であることがより好ましい。このように重合反応終了時の固形分濃度が20質量%以上と高ければ、高濃度かつ一段で重合を行うことができる。そのため、従来の製造方法では場合によっては必要であった濃縮工程を省略することができるなど、効率よく共重合体を含む抗カビ剤を得ることができる。それゆえ、その製造効率を大幅に上昇させたものとすることができ、その結果、本発明の抗カビ剤の生産性を大幅に向上し、製造コストの上昇も抑制することが可能となる。 20 mass% or more is preferable and, as for the solid content density|concentration (namely, polymerization solid content density of a monomer) in an aqueous solution at the time of the completion of the polymerization reaction in the said polymerization reaction system, it is more preferable that it is 25 to 80 mass %. . Thus, if the solid content concentration at the end of the polymerization reaction is as high as 20% by mass or more, the polymerization can be carried out at a high concentration and in a single stage. Therefore, the antifungal agent containing the copolymer can be efficiently obtained, for example, the concentration step which is necessary in the conventional production method can be omitted. Therefore, the production efficiency can be significantly increased, and as a result, the productivity of the antifungal agent of the present invention can be significantly improved and the increase in production cost can be suppressed.
本発明の共重合体の製造方法は、全ての使用原料の添加が終了した以後に、単量体の重合率を上げること等を目的として熟成工程を設けても良い。熟成時間は、通常1〜240分間、好ましくは1〜180分間、より好ましくは1〜120分間である。熟成時間が1分間未満の場合には、熟成不十分につき単量体成分が残ることがあり、残存単量体に起因する毒性や臭気などが問題となる。 In the method for producing the copolymer of the present invention, an aging step may be provided after the addition of all the raw materials used, for the purpose of increasing the polymerization rate of the monomer. The aging time is usually 1 to 240 minutes, preferably 1 to 180 minutes, and more preferably 1 to 120 minutes. When the aging time is less than 1 minute, the monomer component may remain due to insufficient aging, which causes problems such as toxicity and odor due to the residual monomer.
また、熟成工程における好ましい重合体溶液の温度は、上記重合温度と同様の範囲である。したがって、ここでの温度も一定温度(好ましくは上記滴下が終了した時点での温度)で保持してもよいし、熟成中に経時的に温度を変化させてもよい。 Further, the preferable temperature of the polymer solution in the aging step is in the same range as the above-mentioned polymerization temperature. Therefore, the temperature here may be maintained at a constant temperature (preferably the temperature at the time when the dropping is finished), or the temperature may be changed with time during aging.
本発明の抗カビ剤は、本発明の共重合体を抗カビ剤100質量%に対して10〜100質量%含むものである。
本発明の抗カビ剤は、本発明の共重合体以外のその他の成分を含んでいてもよい。
上記その他の成分としては、抗カビ剤の抗カビ性能を阻害するものでない限り特に制限されないが、例えば、アルカリ調整剤、アニオン界面活性剤、相溶化剤や安定化剤等の添加剤等が挙げられる。
また、本発明の抗カビ剤は、抗カビ性を向上させる観点から、更に金属塩や金属酸化物、金属水酸化物などを含んでいてもよい。金属塩又は酸化物、金属水酸化物における金属としては、銅や、亜鉛、銀等の重金属が好ましい。
上記その他の成分の含有量は、抗カビ剤の抗カビ性能を阻害しなければ、特に制限されないが、上記共重合体100質量%に対して、0〜20質量%であることが好ましい。
The antifungal agent of the present invention contains the copolymer of the present invention in an amount of 10 to 100% by mass based on 100% by mass of the antifungal agent.
The antifungal agent of the present invention may contain other components other than the copolymer of the present invention.
The above-mentioned other components are not particularly limited as long as they do not inhibit the antifungal performance of the antifungal agent, and examples thereof include alkali modifiers, anionic surfactants, additives such as compatibilizers and stabilizers, and the like. Be done.
Further, the antifungal agent of the present invention may further contain a metal salt, a metal oxide, a metal hydroxide or the like from the viewpoint of improving the antifungal property. As the metal in the metal salt or oxide or the metal hydroxide, heavy metals such as copper, zinc and silver are preferable.
The content of the other components is not particularly limited as long as it does not inhibit the antifungal performance of the antifungal agent, but is preferably 0 to 20% by mass relative to 100% by mass of the copolymer.
本発明の抗カビ剤は、上述の構成よりなり、抗カビ性能に優れるため、洗濯洗浄剤、柔軟剤、住居用洗剤、食器洗浄剤、硬質表面用洗浄剤等の洗浄剤用途;シャンプー、リンス、化粧水、乳液、クリーム、日焼け止め、ファンデーション、アイメイク製品等の化粧品、制汗剤等の化粧料用途;塗料、木材防腐剤、セメント混和剤、工業用水(製紙工程における抄紙工程水、各種工業用の冷却水や洗浄水)等の工業用途;医療器具、食品添加物、太陽電池モジュールや有機素子デバイス、熱線遮蔽フィルムなどの電子機器用途等に好適に用いることができる。抗カビ剤は上記の用途品の質量100質量%に対して、0.1〜20質量%であることが好ましい。より好ましくは、1〜10質量%である。 Since the antifungal agent of the present invention has the above-mentioned constitution and is excellent in antifungal performance, it is used as a detergent such as a laundry detergent, a softener, a household detergent, a dishwashing agent, a hard surface detergent; shampoo, rinse. , Lotions, emulsions, creams, sunscreens, foundations, cosmetics such as eye-makeup products, cosmetics such as antiperspirants; paints, wood preservatives, cement admixtures, industrial water (papermaking process water in papermaking process, various It can be suitably used for industrial applications such as industrial cooling water and washing water); medical devices, food additives, electronic device applications such as solar cell modules and organic element devices, and heat ray shielding films. The antifungal agent is preferably 0.1 to 20 mass% with respect to 100 mass% of the above-mentioned use product. More preferably, it is 1 to 10 mass %.
上記用途の中でも好ましくは化粧料用途であり、本発明の抗カビ剤を含む化粧料もまた、本発明の1つである。化粧料中の上記抗カビ剤の含有割合は、化粧料100質量%に対して0.1〜20質量%であることが好ましい。より好ましくは1〜10質量%である。 Among the above-mentioned uses, the use for cosmetics is preferable, and the cosmetic containing the antifungal agent of the present invention is also one of the present inventions. The content ratio of the antifungal agent in the cosmetic is preferably 0.1 to 20 mass% with respect to 100 mass% of the cosmetic. It is more preferably 1 to 10% by mass.
本発明の化粧料は、本発明の抗カビ剤以外のその他の成分を含んでいてもよい。
本発明の抗カビ剤と該抗カビ剤以外のその他の成分とを含む化粧料組成物もまた、本発明の1つである。化粧料組成物中の上記抗カビ剤の含有割合は、化粧料組成物100質量%に対して0.1〜20質量%であることが好ましい。より好ましくは1〜10質量%である。
The cosmetic of the present invention may contain other components other than the antifungal agent of the present invention.
A cosmetic composition containing the antifungal agent of the present invention and other components other than the antifungal agent is also one aspect of the present invention. The content ratio of the antifungal agent in the cosmetic composition is preferably 0.1 to 20 mass% with respect to 100 mass% of the cosmetic composition. More preferably, it is 1 to 10 mass %.
上記その他の成分としては特に制限されないが、例えば、油性基剤;グリセリン、プロピレングリコール等の保湿剤・感触向上剤;界面活性剤;高分子;増粘・ゲル化剤;溶剤・噴射剤;酸化防止剤;還元剤、酸化剤;防腐剤・抗菌剤;キレート剤;pH調整剤・酸・アルカリ;粉体類;無機塩類;紫外線吸収剤;美白剤;ビタミン類及びその誘導体類;消炎剤・抗炎症剤;育毛用薬剤・血行促進剤・刺激剤;ホルモン類;抗しわ剤・抗老化剤・ひきしめ剤・冷感剤・温感剤;創傷治癒促進剤・刺激緩和剤・鎮痛剤・細胞賦活剤;植物・動物・微生物エキス類;鎮痒剤、角質剥離・溶解剤;制汗剤;清涼剤;収れん剤;酵素類;核酸類;香料;色素・着色剤・染料・顔料;水等が挙げられる。これらの成分の具体例として特開2007−45776号公報に記載のものと同様のものを用いることができる。 The above-mentioned other components are not particularly limited, but include, for example, oily bases; humectants such as glycerin and propylene glycol; texture improvers; surfactants; polymers; thickening/gelling agents; solvents/propellants; oxidation. Inhibitors; reducing agents, oxidizing agents; antiseptics/antibacterial agents; chelating agents; pH adjusters/acids/alkalis; powders; inorganic salts; ultraviolet absorbers; whitening agents; vitamins and their derivatives; anti-inflammatory agents Anti-inflammatory agents; Hair-growth agents, blood circulation promoters, stimulants; Hormones; Anti-wrinkle agents, anti-aging agents, tightening agents, cooling agents, warming agents; Wound healing accelerators, stimulants, analgesics, cells Activator; Plant/Animal/Microbial extract; Antipruritic, Exfoliating/Solubilizing agent, Antiperspirant, Cooling agent, Astringent, Enzyme, Nucleic acid, Fragrance, Dye/colorant/Dye/Pigment, Water, etc. Can be mentioned. As specific examples of these components, those similar to those described in JP-A 2007-45776 can be used.
以下に実施例を掲げて本発明を更に詳細に説明するが、本発明はこれらの実施例のみに限定されるものではない。なお、特に断りのない限り、「部」は「質量部」を、「%」は「質量%」を意味するものとする。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. In addition, "part" means "part by mass" and "%" means "% by mass" unless otherwise specified.
<ゲルパーミエーションクロマトグラフィー(GPC)>
カチオン性基含有共重合体の重量平均分子量(Mw)は、GPC(ゲルパーミエーションクロマトグラフィー)により測定した。
測定条件、装置などは以下の通りである。
装置:東ソー社製 EcoSEC HLC−8320GPC
検出器:示差屈折率計(RI)検出器
カラム:東ソー社製 TSKgel α−M、α−2500
カラム温度:40℃
流速:0.8mL/min
注入量:10μL(試料濃度0.4wt%の溶離液調製溶液)
検量線:ジーエルサイエンス社製 ポリエチレングリコール
GPCソフト:東ソー社製 EcoSEC−WS
溶離液:0.5M酢酸+0.2M硝酸Na/アセトニトリル=50/50(v/v)
<Gel permeation chromatography (GPC)>
The weight average molecular weight (Mw) of the cationic group-containing copolymer was measured by GPC (gel permeation chromatography).
The measurement conditions and equipment are as follows.
Device: Tosoh EcoSEC HLC-8320GPC
Detector: Differential Refractive Index (RI) Detector Column: Tosoh TSKgel α-M, α-2500
Column temperature: 40°C
Flow rate: 0.8 mL/min
Injection volume: 10 μL (eluent preparation solution with a sample concentration of 0.4 wt%)
Calibration curve: GL Sciences polyethylene glycol GPC software: Tosoh EcoSEC-WS
Eluent: 0.5 M acetic acid + 0.2 M Na nitrate/acetonitrile = 50/50 (v/v)
<抗カビ能の測定>
1)ポテトデキストロース寒天(PDA)斜面培地にクロカビ(Cladosporium cladosporioides NBRC30314)を植菌し、30℃で1週間前培養した。
2)生育したクロカビから胞子懸濁液を調製し、血球盤で胞子数をカウントして適宜希釈することにより約5.0×104 spores/mlの濃度に調整した。この時、調整後の胞子懸濁液を適宜希釈してPDA培地に100μL塗布し、30℃で3日間培養することにより、実際の生菌数を求め、これを初期の生菌数αとした。
3)1.5mlチューブにカチオン性基含有共重合体の20%水溶液500μLと調整後の胞子懸濁液500μLを入れ、ツインミキサーで撹拌した。攪拌180分後の試料をPDA培地に100μl塗抹し、30℃で3日間培養した。撹拌180分後の試料中の生菌数をβとした。
4)下記式(1)により抗カビ能を算出した。
抗カビ能=2−log[(β/α)×100](1)
<Measurement of antifungal ability>
1) Potato dextrose agar (PDA) slant medium was inoculated with black mold (Cladosporium cladosporioides NBRC30314) and precultured at 30° C. for 1 week.
2) A spore suspension was prepared from the grown Aspergillus niger, and the number of spores was counted by a blood cell disc and appropriately diluted to adjust the concentration to about 5.0×10 4 pores/ml. At this time, the adjusted spore suspension was appropriately diluted, applied to a PDA medium in an amount of 100 μL, and cultured at 30° C. for 3 days to obtain the actual viable cell count, which was defined as the initial viable cell count α. ..
3) Into a 1.5 ml tube, 500 μL of a 20% aqueous solution of the copolymer containing a cationic group and 500 μL of the adjusted spore suspension were placed and stirred with a twin mixer. After 180 minutes of stirring, 100 μl of the sample was smeared on a PDA medium and cultured at 30° C. for 3 days. The viable cell count in the sample after 180 minutes of stirring was defined as β.
4) The antifungal ability was calculated by the following formula (1).
Antifungal ability=2-log [(β/α)×100] (1)
<菌糸体成長阻害の測定>
1)ポテトデキストロース寒天(PDA)培地(富士フイルム和光純薬製)粉末1.95gに45gの純水を加えたのちに、121℃で20分間、オートクレーブにて滅菌した。上記滅菌後のPDA培地を取り出した後に約60℃に降温してから、10%ポリマー水溶液5gを加えて混合し、プレートに入れて固めて検定培地を調製した。
2)別のPDA培地にコウジカビ(Aspergillus brasiliensis NBRC9455)を植菌し、25℃で約1週間培養した。
3)コウジカビが生育した培地を直径4mmのコルクボーラーでくり抜いて菌叢ディスクを作成し、菌糸の生長面を下にして検定培地に載せた。
4)25℃で3日間培養し、菌叢ディスクを含めたコロニーサイズ(mm)を測定した。
上記コロニーサイズを下記表3において、菌糸体成長阻害(mm)として示した。
<Measurement of mycelium growth inhibition>
1) 45 g of pure water was added to 1.95 g of powder of potato dextrose agar (PDA) medium (manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.), and then sterilized by autoclave at 121° C. for 20 minutes. The sterilized PDA medium was taken out and then cooled to about 60° C., 5 g of a 10% polymer aqueous solution was added and mixed, and the mixture was put into a plate and solidified to prepare an assay medium.
2) Another PDA medium was inoculated with Aspergillus brasiliensis NBRC9455 and cultured at 25°C for about 1 week.
3) A medium in which Aspergillus niger had grown was cut out with a cork borer having a diameter of 4 mm to prepare a flora disk, which was placed on the assay medium with the growth surface of mycelium facing down.
4) The cells were cultured at 25°C for 3 days, and the colony size (mm) including the flora disc was measured.
The colony size is shown in Table 3 below as mycelial growth inhibition (mm).
<合成例1>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、1,3−ブタンジオール(以下、BGと略す)70.0gを仕込み、撹拌下、75℃に昇温した。次いで、撹拌下、75℃一定状態の重合反応系中に、メタクリル酸2−(ジメチルアミノ)エチル(以下、DAMと略す)81.0g、酢酸31.0g、メタクリル酸エチル(以下、EMAと略す。溶解性パラメータ:9.7)9.0g、2,2’−アゾビス[2−(2−イミダゾリン−2−イル)プロパン]二塩酸塩(以下、VA−044と略す)の15%水溶液35.7gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、酢酸とEMAは180分間、VA−044の15%水溶液は210分間滴下した。全滴下終了後、さらに30分間反応溶液を75℃に保持して熟成し、重合を完結させた。後に、純水45.8gを加え、共重合体1を得た。
得られた共重合体1の固形分は33.4%、pHは6.4、重量平均分子量は11,000であった。
<Synthesis example 1>
A glass separable flask equipped with a thermometer, a reflux condenser, and a stirrer was charged with 70.0 g of 1,3-butanediol (hereinafter abbreviated as BG), and the temperature was raised to 75°C with stirring. Then, under stirring, in a polymerization reaction system at a constant temperature of 75° C., 81.0 g of 2-(dimethylamino)ethyl methacrylate (hereinafter abbreviated as DAM), 31.0 g of acetic acid, ethyl methacrylate (hereinafter abbreviated as EMA). Solubility parameter: 9.7) 9.0 g of a 15% aqueous solution of 2,2'-azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride (hereinafter abbreviated as VA-044) 35. 0.7 g was dropped from separate dropping nozzles. With respect to the dropping time, the dropping was started at the same time, and DAM, acetic acid and EMA were dropped for 180 minutes, and a 15% aqueous solution of VA-044 was dropped for 210 minutes. After the completion of all droppings, the reaction solution was kept at 75° C. for 30 minutes for aging to complete the polymerization. After that, 45.8 g of pure water was added to obtain a copolymer 1.
The solid content of the obtained copolymer 1 was 33.4%, the pH was 6.4, and the weight average molecular weight was 11,000.
<合成例2>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG70.0gを仕込み、撹拌下、90℃に昇温した。次いで、撹拌下、90℃一定状態の重合反応系中に、DAM81.0g、酢酸31.0g、EMA9.0g、2,2’−アゾビス(2−メチルプロピオンアミジン)二塩酸塩(以下、V−50と略す)の5%水溶液27.3gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAMと酢酸は180分間、EMAは170分間、V−50の5%水溶液は210分間滴下した。全滴下終了後、さらに30分間反応溶液を90℃に保持して熟成し、重合を完結させた。後に、純水42.7gを加え、共重合体2を得た。
得られた共重合体2の固形分は33.2%、pHは6.3、重量平均分子量は27,000であった。
<Synthesis example 2>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 70.0 g of BG and heated to 90° C. under stirring. Then, under stirring, in a polymerization reaction system at a constant temperature of 90° C., 81.0 g of DAM, 31.0 g of acetic acid, 9.0 g of EMA, 2,2′-azobis(2-methylpropionamidine) dihydrochloride (hereinafter, referred to as V- 27.3 g of a 5% aqueous solution (abbreviated as 50) was dropped from separate dropping nozzles. With respect to the dropping time, all of the dropping was started at the same time, DAM and acetic acid were added for 180 minutes, EMA was added for 170 minutes, and a 5% aqueous solution of V-50 was added for 210 minutes. After the completion of all droppings, the reaction solution was kept at 90° C. for another 30 minutes for aging to complete the polymerization. After that, 42.7 g of pure water was added to obtain a copolymer 2.
The solid content of the obtained copolymer 2 was 33.2%, the pH was 6.3, and the weight average molecular weight was 27,000.
<合成例3>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG70.0gを仕込み、撹拌下、75℃に昇温した。次いで、撹拌下、75℃一定状態の重合反応系中に、DAM72.0g、酢酸33.0g、EMA18.0g、VA−044の5%水溶液36.7gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、酢酸とEMAは180分間、VA−044の5%水溶液は210分間滴下した。全滴下終了後、さらに30分間反応溶液を75℃に保持して熟成し、重合を完結させた。後に、純水32.8gを加え、共重合体3を得た。
得られた共重合体3の固形分は31.4%、pHは6.2、重量平均分子量は29,000であった。
<Synthesis example 3>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 70.0 g of BG and heated to 75° C. under stirring. Then, with stirring, 72.0 g of DAM, 33.0 g of acetic acid, 18.0 g of EMA, and 36.7 g of a 5% aqueous solution of VA-044 were dropped into the polymerization reaction system at a constant temperature of 75° C. from separate dropping nozzles. With respect to the dropping time, the dropping was all started at the same time, and DAM, acetic acid and EMA were dropped for 180 minutes, and a 5% aqueous solution of VA-044 was dropped for 210 minutes. After the completion of all droppings, the reaction solution was kept at 75° C. for 30 minutes for aging to complete the polymerization. After that, 32.8 g of pure water was added to obtain a copolymer 3.
The solid content of the obtained copolymer 3 was 31.4%, the pH was 6.2, and the weight average molecular weight was 29,000.
<合成例4>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、純水50.0gとPG22.0gを仕込み、撹拌下、90℃に昇温した。次いで、撹拌下、90℃一定状態の重合反応系中に、DAM63.0g、酢酸24.1g、BA22.5g、メタクリル酸(以下、MAAと略す)4.5g、純水21.1g、V−50の5%水溶液31.4gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、酢酸、BAは180分間、MAA、純水、V−50の5%水溶液は210分間滴下した。全滴下終了後、さらに90分間反応溶液を90℃に保持して熟成し、重合を完結させ、共重合体4を得た。
得られた共重合体4の固形分は34.9%、pHは6.0、重量平均分子量は27,000であった。
<Synthesis example 4>
A glass separable flask equipped with a thermometer, a reflux condenser, and a stirrer was charged with 50.0 g of pure water and 22.0 g of PG, and the temperature was raised to 90° C. with stirring. Then, under stirring, in a polymerization reaction system at a constant temperature of 90° C., DAM 63.0 g, acetic acid 24.1 g, BA 22.5 g, methacrylic acid (hereinafter abbreviated as MAA) 4.5 g, pure water 21.1 g, V- 31.4 g of 50% 5% aqueous solution was added dropwise from separate dropping nozzles. With regard to the dropping time, the dropping was all started simultaneously, and DAM, acetic acid and BA were dropped for 180 minutes, and MAA, pure water and a 5% aqueous solution of V-50 were dropped for 210 minutes. After the completion of all droppings, the reaction solution was kept at 90° C. for 90 minutes for aging to complete the polymerization, whereby a copolymer 4 was obtained.
The solid content of the obtained copolymer 4 was 34.9%, the pH was 6.0, and the weight average molecular weight was 27,000.
<合成例5>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG70.0gを仕込み、撹拌下、75℃に昇温した。次いで、撹拌下、75℃一定状態の重合反応系中に、DAM81.0g、酢酸31.0g、メタクリル酸ラウリル(以下、LMAと略す。溶解性パラメータ:9.0)9.0g、VA−044の15%水溶液36.7gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、酢酸とLMAは180分間、VA−044の15%水溶液は210分間滴下した。全滴下終了後、さらに30分間反応溶液を75℃に保持して熟成し、重合を完結させた。後に、純水45.2gを加え、共重合体5を得た。
得られた共重合体5の固形分は32.6%、pHは6.3、重量平均分子量は11,000であった。
<Synthesis example 5>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 70.0 g of BG and heated to 75° C. under stirring. Then, with stirring, in a polymerization reaction system at a constant temperature of 75° C., 81.0 g of DAM, 31.0 g of acetic acid, 9.0 g of lauryl methacrylate (hereinafter abbreviated as LMA. Solubility parameter: 9.0), VA-044. 36.7 g of 15% aqueous solution of was added dropwise from separate dropping nozzles. With respect to the dropping time, the dropping was all started at the same time, and DAM, acetic acid and LMA were dropped for 180 minutes, and a 15% aqueous solution of VA-044 was dropped for 210 minutes. After the completion of all droppings, the reaction solution was kept at 75° C. for 30 minutes for aging to complete the polymerization. After that, 45.2 g of pure water was added to obtain a copolymer 5.
The solid content of the obtained copolymer 5 was 32.6%, the pH was 6.3, and the weight average molecular weight was 11,000.
<合成例6>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、純水50.0gとBG30.0gを仕込み、撹拌下、90℃に昇温した。次いで、撹拌下、90℃一定状態の重合反応系中に、DAM72.0g、酢酸27.5g、アクリル酸ブチル(以下、BAと略す。溶解性パラメータ:9.8)18.0g、V−50の5%水溶液29.9gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、酢酸とBAは180分間、V−50の5%水溶液は240分間滴下した。全滴下終了後、さらに60分間反応溶液を90℃に保持して熟成し、重合を完結させた。後に、純水50.0gを加え、共重合体6を得た。
得られた共重合体6の固形分は30.2%、pHは6.5、重量平均分子量は27,000であった。
<Synthesis example 6>
A glass separable flask equipped with a thermometer, a reflux condenser, and a stirrer was charged with 50.0 g of pure water and 30.0 g of BG, and the temperature was raised to 90° C. with stirring. Then, under stirring, in a polymerization reaction system at a constant temperature of 90° C., 72.0 g of DAM, 27.5 g of acetic acid, butyl acrylate (hereinafter abbreviated as BA, solubility parameter: 9.8) 18.0 g, V-50. 29.9 g of a 5% aqueous solution of was added dropwise from separate dropping nozzles. With respect to the dropping time, the dropping was all started at the same time, and DAM, acetic acid and BA were dropped for 180 minutes, and a 5% aqueous solution of V-50 was dropped for 240 minutes. After the completion of all droppings, the reaction solution was kept at 90° C. for further 60 minutes for aging to complete the polymerization. After that, 50.0 g of pure water was added to obtain a copolymer 6.
The solid content of the obtained copolymer 6 was 30.2%, the pH was 6.5, and the weight average molecular weight was 27,000.
<合成例7>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、純水24.0gとプロピレングリコール(以下、PGと略す)72.0gを仕込み、撹拌下、90℃に昇温した。次いで、撹拌下、90℃一定状態の重合反応系中に、DAM54.0g、酢酸20.6g、BA36.0g、V−50の3%水溶液33.3gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、酢酸とBAは180分間、V−50の3%水溶液は210分間滴下した。全滴下終了後、さらに90分間反応溶液を90℃に保持して熟成し、重合を完結させ、共重合体7を得た。
得られた共重合体7の固形分は34.2%、pHは6.7、重量平均分子量は25,000であった。
<Synthesis example 7>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 24.0 g of pure water and 72.0 g of propylene glycol (hereinafter abbreviated as PG), and the temperature was raised to 90° C. with stirring. Then, under stirring, 54.0 g of DAM, 20.6 g of acetic acid, 36.0 g of BA, and 33.3 g of a 3% aqueous solution of V-50 were dropped into the polymerization reaction system at a constant temperature of 90° C. from separate dropping nozzles. With respect to the dropping time, all of them were started at the same time, and DAM, acetic acid and BA were dropped for 180 minutes, and a 3% aqueous solution of V-50 was dropped for 210 minutes. After the completion of all droppings, the reaction solution was kept at 90° C. for 90 minutes for aging to complete the polymerization, whereby a copolymer 7 was obtained.
The solid content of the obtained copolymer 7 was 34.2%, the pH was 6.7, and the weight average molecular weight was 25,000.
<合成例8>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、純水18.0gとPG72.0gを仕込み、撹拌下、90℃に昇温した。次いで、撹拌下、90℃一定状態の重合反応系中に、メタクリル酸2−(ジエチルアミノ)エチル(以下、DEAMと略す)72.0g、酢酸23.3g、BA18.0g、V−50の5%水溶液31.7gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DEAM、酢酸とBAは180分間、V−50の5%水溶液は210分間滴下した。全滴下終了後、さらに90分間反応溶液を90℃に保持して熟成し、重合を完結させ、共重合体8を得た。
得られた共重合体8の固形分は35.8%、pHは6.8、重量平均分子量は13,000であった。
<Synthesis example 8>
A glass separable flask equipped with a thermometer, a reflux condenser, and a stirrer was charged with 18.0 g of pure water and 72.0 g of PG, and the temperature was raised to 90° C. with stirring. Then, under stirring, in a polymerization reaction system at 90° C., 72.0 g of 2-(diethylamino)ethyl methacrylate (hereinafter abbreviated as DEAM), 23.3 g of acetic acid, 18.0 g of BA, 5% of V-50. 31.7 g of the aqueous solution was dropped from separate dropping nozzles. With regard to the dropping time, all the dropping was started at the same time, and DEAM, acetic acid and BA were dropped for 180 minutes, and a 5% aqueous solution of V-50 was dropped for 210 minutes. After the completion of all droppings, the reaction solution was kept at 90° C. for 90 minutes for aging to complete the polymerization, whereby a copolymer 8 was obtained.
The obtained copolymer 8 had a solid content of 35.8%, a pH of 6.8 and a weight average molecular weight of 13,000.
<合成例9>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG70.0gを仕込み、撹拌下、80℃に昇温した。次いで、撹拌下、80℃一定状態の重合反応系中に、DEAM45.0g、酢酸14.6g、BA45.0g、VA−044の5%水溶液35.6gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DEAMと酢酸は180分間、BAは140分間、VA−044の5%水溶液は240分間滴下した。全滴下終了後、さらに60分間反応溶液を80℃に保持して熟成し、重合を完結させ、共重合体9を得た。
得られた共重合体9の固形分は35.2%、pHは5.6、重量平均分子量は13,000であった。
<Synthesis example 9>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 70.0 g of BG and heated to 80° C. under stirring. Then, with stirring, 45.0 g of DEAM, 14.6 g of acetic acid, 45.0 g of BA, and 35.6 g of a 5% aqueous solution of VA-044 were added dropwise from separate dropping nozzles into the polymerization reaction system at a constant temperature of 80°C. With respect to the dropping time, all of them were started at the same time, DEAM and acetic acid were added for 180 minutes, BA was added for 140 minutes, and a 5% aqueous solution of VA-044 was added for 240 minutes. After the completion of all droppings, the reaction solution was kept at 80° C. for 60 minutes for aging to complete the polymerization, and a copolymer 9 was obtained.
The solid content of the obtained copolymer 9 was 35.2%, the pH was 5.6, and the weight average molecular weight was 13,000.
<合成例10>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG70.0gを仕込み、撹拌下、80℃に昇温した。次いで、撹拌下、80℃一定状態の重合反応系中に、DEAM72.0g、酢酸23.3g、アクリル酸イソブチル(以下iso−BAと略す)18.0g、VA−044の7.5%水溶液31.7gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DEAMと酢酸は180分間、iso−BAは150分間、VA−044の7.5%水溶液は240分間滴下した。全滴下終了後、さらに60分間反応溶液を80℃に保持して熟成し、重合を完結させ、共重合体10を得た。
得られた共重合体10の固形分は35.9%、pHは6.0、重量平均分子量は15,000であった。
<Synthesis example 10>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 70.0 g of BG and heated to 80° C. under stirring. Then, under stirring, in a polymerization reaction system at a constant temperature of 80° C., 72.0 g of DEAM, 23.3 g of acetic acid, 18.0 g of isobutyl acrylate (hereinafter abbreviated as iso-BA), and a 7.5% aqueous solution of VA-044 31 0.7 g was dropped from separate dropping nozzles. With respect to the dropping time, all of them were started at the same time, DEAM and acetic acid were added for 180 minutes, iso-BA was added for 150 minutes, and a 7.5% aqueous solution of VA-044 was added for 240 minutes. After the completion of all droppings, the reaction solution was kept at 80° C. for 60 minutes for aging to complete the polymerization, and thus a copolymer 10 was obtained.
The solid content of the obtained copolymer 10 was 35.9%, the pH was 6.0, and the weight average molecular weight was 15,000.
<合成例11>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG70.0gを仕込み、撹拌下、80℃に昇温した。次いで、撹拌下、80℃一定状態の重合反応系中に、DEAM72.0g、酢酸23.3g、アクリル酸t−ブチル(以下t−BAと略す)18.0g、VA−044の7.5%水溶液31.7gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DEAMと酢酸は180分間、t−BAは170分間、VA−044の7.5%水溶液は240分間滴下した。全滴下終了後、さらに60分間反応溶液を80℃に保持して熟成し、重合を完結させ、共重合体11を得た。
得られた共重合体11の固形分は35.5%、pHは6.1、重量平均分子量は13,000であった。
<Synthesis example 11>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 70.0 g of BG and heated to 80° C. under stirring. Then, with stirring, in a polymerization reaction system at a constant temperature of 80° C., 72.0 g of DEAM, 23.3 g of acetic acid, 18.0 g of t-butyl acrylate (hereinafter abbreviated as t-BA), and 7.5% of VA-044. 31.7 g of the aqueous solution was dropped from separate dropping nozzles. With respect to the dropping time, all the dropping was started at the same time, DEAM and acetic acid were added for 180 minutes, t-BA was added for 170 minutes, and a 7.5% aqueous solution of VA-044 was added for 240 minutes. After the completion of all droppings, the reaction solution was kept at 80° C. for further 60 minutes for aging to complete the polymerization, whereby a copolymer 11 was obtained.
The solid content of the obtained copolymer 11 was 35.5%, the pH was 6.1, and the weight average molecular weight was 13,000.
<比較合成例1>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG70.0gを仕込み、撹拌下、90℃に昇温した。次いで、撹拌下、90℃一定状態の重合反応系中に、DAM90.0g、酢酸34.4g、V−50の5%水溶液34.4gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、と酢酸は120分間、V−50の5%水溶液は180分間滴下した。全滴下終了後、さらに60分間反応溶液を90℃に保持して熟成し、重合を完結させ、比較共重合体1を得た。
得られた比較共重合体1の固形分は39.6%、pHは7.2、重量平均分子量は19,000であった。
<Comparative Synthesis Example 1>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 70.0 g of BG and heated to 90° C. under stirring. Then, under stirring, 90.0 g of DAM, 34.4 g of acetic acid, and 34.4 g of a 5% aqueous solution of V-50 were dropped from separate dropping nozzles into the polymerization reaction system at a constant temperature of 90°C. With regard to the dropping time, all of them were started at the same time, and DAM and acetic acid were added for 120 minutes, and a 5% aqueous solution of V-50 was added for 180 minutes. After the completion of all droppings, the reaction solution was kept at 90° C. for 60 minutes for aging to complete the polymerization, whereby Comparative Copolymer 1 was obtained.
The obtained comparative copolymer 1 had a solid content of 39.6%, a pH of 7.2, and a weight average molecular weight of 19,000.
<比較合成例2>
温度計、還流冷却器、攪拌機を備えたガラス製のセパラブルフラスコに、BG90.0gを仕込み、撹拌下、90℃に昇温した。次いで、撹拌下、90℃一定状態の重合反応系中に、DAM31.5g、酢酸12.0g、EMA58.5g、V−50の7%水溶液35.7gを、それぞれ別々の滴下ノズルより滴下した。滴下時間に関して、全て同時に滴下を開始し、DAM、酢酸とEMAは120分間、V−50の7%水溶液は180分間滴下した。全滴下終了後、さらに60分間反応溶液を90℃に保持して熟成し、重合を完結させた。後に、純水36.6gを加え、比較共重合体2を得た。
得られた比較共重合体2の固形分は35.5%、pHは6.6、重量平均分子量は33,000であった。
<Comparative Synthesis Example 2>
A glass separable flask equipped with a thermometer, a reflux condenser and a stirrer was charged with 90.0 g of BG and heated to 90° C. under stirring. Then, under stirring, 31.5 g of DAM, 12.0 g of acetic acid, 58.5 g of EMA, and 35.7 g of a 7% aqueous solution of V-50 were added dropwise to the polymerization reaction system at 90° C. under constant conditions. With respect to the dropping time, all of them were started at the same time, DAM, acetic acid and EMA were added for 120 minutes, and a 7% aqueous solution of V-50 was added for 180 minutes. After the completion of all droppings, the reaction solution was kept at 90° C. for further 60 minutes for aging to complete the polymerization. Then, 36.6 g of pure water was added to obtain Comparative Copolymer 2.
The obtained comparative copolymer 2 had a solid content of 35.5%, a pH of 6.6 and a weight average molecular weight of 33,000.
<実施例1−1〜1−11及び比較例1−1、1−2>
合成例1〜11及び比較合成例1、2で得られた共重合体について、抗カビ性試験を行った。結果を表1に示した。
<Examples 1-1 to 1-11 and Comparative Examples 1-1 and 1-2>
Antifungal tests were conducted on the copolymers obtained in Synthesis Examples 1 to 11 and Comparative Synthesis Examples 1 and 2. The results are shown in Table 1.
<実施例2−1及び比較例2−1>
合成例3で得られた共重合体について、化粧水配合での抗カビ性試験を行った。
抗カビ能の測定においてカチオン性基含有共重合体の20%水溶液の代わりに、グリセリン10%/プロピレングリコール8%/カチオン性基含有共重合体10%水溶液を用いて抗カビ性試験を実施した。結果を表2に示した。
<Example 2-1 and Comparative Example 2-1>
The copolymer obtained in Synthetic Example 3 was tested for antifungal properties in a lotion formulation.
In the measurement of the antifungal ability, the antifungal test was carried out using a 10% aqueous solution of glycerin/8% propylene glycol/8% cationic group-containing copolymer instead of the 20% aqueous solution of the cationic group-containing copolymer. .. The results are shown in Table 2.
<実施例3−1〜3−6及び比較例3−1>
合成例2、3、5、6、9、10及び比較合成例1で得られた共重合体について、菌糸体成長阻害の測定を行った。結果を表3に示した。
<Examples 3-1 to 3-6 and Comparative Example 3-1>
For the copolymers obtained in Synthesis Examples 2, 3, 5, 6, 9, 10 and Comparative Synthesis Example 1, mycelium growth inhibition was measured. The results are shown in Table 3.
Claims (5)
該抗カビ剤は、下記の方法により測定される抗カビ能が2.0以上であり、
該カチオン性基含有共重合体は、カチオン性基含有単量体(A)由来の構造単位(a)と単量体(B)由来の構造単位(b)を有し、該カチオン性基含有単量体(A)由来の構造単位(a)の割合が、全構造単位100質量%に対して36〜99.9質量%であり、該単量体(B)は、単独重合体の溶解性パラメータが10以下である単量体(B1)、並びに、カルボキシル基、水酸基及びエーテル基からなる群より選択される少なくとも1種の官能基を有する単量体(B2)、から選択される1種以上の単量体であり、該カチオン性基含有共重合体の重量平均分子量が4000〜100万であり、抗カビ剤に含まれる該カチオン性基含有共重合体の割合が抗カビ剤100質量%に対して10〜100質量%であることを特徴とする抗カビ剤。
<抗カビ能の測定>
1)ポテトデキストロース寒天(PDA)斜面培地にクロカビ(Cladosporium cladosporioides)を植菌し、30℃で1週間前培養する。
2)生育したクロカビから胞子懸濁液を調製し、血球盤で胞子数をカウントして適宜希釈することにより約5.0×104 spores/mlの濃度に調整する。この時、調整後の胞子懸濁液を適宜希釈してPDA培地に100μL塗布し、30℃で3日間培養することにより、実際の生菌数を求め、これを初期の生菌数αとする。
3)1.5mlチューブに当該カチオン性基含有共重合体の20%水溶液500μLと調整後の胞子懸濁液500μLを入れ、ツインミキサーで撹拌する。攪拌180分後の試料をPDA培地に100μl塗抹し、30℃で3日間培養することにより、生菌数を求め、これを撹拌180分後の試料中の生菌数βとする。
4)下記式(1)により抗カビ能を算出する。
抗カビ能=2−log[(β/α)×100](1) An antifungal agent containing a cationic group-containing copolymer,
The antifungal agent has an antifungal ability of 2.0 or more as measured by the following method,
The cationic group-containing copolymer has the structural unit (a) derived from the cationic group-containing monomer (A) and the structural unit (b) derived from the monomer (B), and contains the cationic group. The proportion of the structural unit (a) derived from the monomer (A) is 36 to 99.9% by mass with respect to 100% by mass of all structural units, and the monomer (B) is a homopolymer dissolved therein. 1 selected from a monomer (B1) having a sex parameter of 10 or less, and a monomer (B2) having at least one functional group selected from the group consisting of a carboxyl group, a hydroxyl group and an ether group. One or more kinds of monomers, the weight average molecular weight of the cationic group-containing copolymer is 4000 to 1,000,000, and the ratio of the cationic group-containing copolymer contained in the antifungal agent is 100. An antifungal agent characterized by being 10 to 100% by mass relative to% by mass.
<Measurement of antifungal ability>
1) Potato dextrose agar (PDA) slant medium is inoculated with black mold (Cladosporium cladosporioides) and precultured at 30° C. for 1 week.
2) A spore suspension is prepared from the grown black mold, and the number of spores is counted in a blood cell plate and appropriately diluted to adjust the concentration to about 5.0×10 4 pores/ml. At this time, the adjusted spore suspension is appropriately diluted, applied to a PDA medium in an amount of 100 μL, and cultured at 30° C. for 3 days to obtain the actual viable cell count, which is used as the initial viable cell count α. .
3) Into a 1.5 ml tube, 500 μL of a 20% aqueous solution of the cationic group-containing copolymer and 500 μL of the adjusted spore suspension are put and stirred with a twin mixer. 100 μl of the sample after 180 minutes of stirring is smeared on a PDA medium and cultured at 30° C. for 3 days to obtain the viable cell count, which is defined as the viable cell number β in the sample after 180 minutes of stirring.
4) The antifungal ability is calculated by the following formula (1).
Antifungal ability=2-log [(β/α)×100] (1)
前記カチオン性基含有共重合体は、全構造単位100質量%に対して、カルボキシル基含有単量体(B2−1)に由来する構造単位(b2−1)を1.0〜30質量%の割合で有することを特徴とする請求項1〜3に記載の抗カビ剤。 The monomer (B) contains at least one kind of a carboxyl group-containing monomer (B2-1),
The cationic group-containing copolymer contains 1.0 to 30% by mass of the structural unit (b2-1) derived from the carboxyl group-containing monomer (B2-1) based on 100% by mass of all structural units. The antifungal agent according to claims 1 to 3, wherein the antifungal agent is contained in a ratio.
該化粧料は、抗カビ剤を化粧料100質量%に対して0.1〜20質量%の割合で含むことを特徴とする化粧料。 A cosmetic containing the antifungal agent according to any one of claims 1 to 4,
The cosmetic comprises an antifungal agent in a ratio of 0.1 to 20 mass% with respect to 100 mass% of the cosmetic.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018212193 | 2018-11-12 | ||
JP2018212193 | 2018-11-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020079239A true JP2020079239A (en) | 2020-05-28 |
JP7430516B2 JP7430516B2 (en) | 2024-02-13 |
Family
ID=70801445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019204773A Active JP7430516B2 (en) | 2018-11-12 | 2019-11-12 | anti-fungal agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7430516B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0236106A (en) * | 1988-03-03 | 1990-02-06 | Sumitomo Chem Co Ltd | Germicide and germicidal resin composition containing ethylenic copolymer as active ingredient |
JP2013203697A (en) * | 2012-03-28 | 2013-10-07 | Nicca Chemical Co Ltd | Antibacterial and antifungal agent and antibacterial and antifungal product |
WO2017057571A1 (en) * | 2015-09-30 | 2017-04-06 | 株式会社日本触媒 | Antibacterial agent |
JP2017214346A (en) * | 2015-09-30 | 2017-12-07 | 株式会社日本触媒 | Antibacterial agent |
-
2019
- 2019-11-12 JP JP2019204773A patent/JP7430516B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0236106A (en) * | 1988-03-03 | 1990-02-06 | Sumitomo Chem Co Ltd | Germicide and germicidal resin composition containing ethylenic copolymer as active ingredient |
JP2013203697A (en) * | 2012-03-28 | 2013-10-07 | Nicca Chemical Co Ltd | Antibacterial and antifungal agent and antibacterial and antifungal product |
WO2017057571A1 (en) * | 2015-09-30 | 2017-04-06 | 株式会社日本触媒 | Antibacterial agent |
JP2017214346A (en) * | 2015-09-30 | 2017-12-07 | 株式会社日本触媒 | Antibacterial agent |
Also Published As
Publication number | Publication date |
---|---|
JP7430516B2 (en) | 2024-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6329229B2 (en) | Antibacterial agent | |
EP3166650B1 (en) | Hydrogel compositions | |
EP3551679B1 (en) | Polymer comprising certain level of bio-based carbon | |
EP2507275B1 (en) | Hydrolytically stable multi-purpose polymers | |
WO2017057571A1 (en) | Antibacterial agent | |
MX2008010700A (en) | Polymerizable silicone copolyol macromers and polymers made therefrom. | |
WO2018108610A1 (en) | Polymer comprising certain level of bio-based carbon | |
JP2020507634A (en) | Polymers containing certain levels of biobased carbon | |
JP2015503639A (en) | Process for preparing acrylic polymers and products produced thereby | |
JP2013521364A (en) | Anionic associative rheology modifier | |
EP2542598A1 (en) | Anionic associative rheology modifiers | |
JP2011072851A (en) | Scale inhibitor containing amino group-containing copolymer | |
JP7430516B2 (en) | anti-fungal agent | |
CN111164149B (en) | Inverse emulsion thickener | |
JP2015172028A (en) | cosmetic | |
JP6757181B2 (en) | Antibacterial agent | |
US8623977B2 (en) | Non-hydrocarbyl hydrophobically modified polycarboxylic polymers | |
JPH10226715A (en) | Microparticulate crosslinked n-vinylamide resin | |
JP7161856B2 (en) | Fiber treatment agent | |
JP6981963B2 (en) | Gel composition, cosmetics, and method for producing gel composition | |
EP2561859A1 (en) | Rheology modifiers for surfactant formulations | |
JP2002521505A (en) | Method for producing powdery crosslinked polymer | |
JP2021015232A (en) | Antiamoebic agent | |
JP2023007391A (en) | Composition containing cationic group-containing polymer | |
CN117586447A (en) | Fast wetting type ion-resistant carbomer and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220805 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230613 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230620 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230821 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231003 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231120 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240116 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240131 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7430516 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |